| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | dynein light intermediate chain binding | 8.74e-07 | 28 | 128 | 5 | GO:0051959 | |
| GeneOntologyMolecularFunction | ATP-dependent chromatin remodeler activity | 3.70e-06 | 37 | 128 | 5 | GO:0140658 | |
| GeneOntologyMolecularFunction | histone modifying activity | 1.71e-05 | 229 | 128 | 9 | GO:0140993 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | DNHD1 EP400 DNAH10 AK9 SRCAP MDN1 G3BP1 CHD5 ATAD2B DNAI2 SMARCA2 SMARCA4 ACIN1 DNAH11 | 4.04e-05 | 614 | 128 | 14 | GO:0140657 |
| GeneOntologyMolecularFunction | catalytic activity, acting on DNA | 4.92e-05 | 262 | 128 | 9 | GO:0140097 | |
| GeneOntologyMolecularFunction | chromatin binding | ZEB1 EP400 CENPB POLE KAT6A APP SARNP CHD5 ATAD2B SKOR2 SMARCA2 SMARCA4 TAF5 NIPBL KDM1A | 7.92e-05 | 739 | 128 | 15 | GO:0003682 |
| GeneOntologyMolecularFunction | ATP-dependent activity, acting on DNA | 1.69e-04 | 127 | 128 | 6 | GO:0008094 | |
| GeneOntologyMolecularFunction | minus-end-directed microtubule motor activity | 1.96e-04 | 18 | 128 | 3 | GO:0008569 | |
| GeneOntologyMolecularFunction | histone binding | 3.14e-04 | 265 | 128 | 8 | GO:0042393 | |
| GeneOntologyMolecularFunction | helicase activity | 5.47e-04 | 158 | 128 | 6 | GO:0004386 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | DNAH10 AK9 SRCAP MDN1 G3BP1 CHD5 ATAD2B SMARCA4 ACIN1 DNAH11 | 5.57e-04 | 441 | 128 | 10 | GO:0016887 |
| GeneOntologyMolecularFunction | histone H3K9me2/H3K9me3 demethylase activity | 6.01e-04 | 6 | 128 | 2 | GO:0140684 | |
| GeneOntologyMolecularFunction | histone H3 demethylase activity | 7.50e-04 | 28 | 128 | 3 | GO:0141052 | |
| GeneOntologyMolecularFunction | transcription coactivator activity | 7.60e-04 | 303 | 128 | 8 | GO:0003713 | |
| GeneOntologyMolecularFunction | transcription coregulator activity | KDM4C PHF12 KAT6A NACA GON4L SRCAP UBE3A SMARCA2 SMARCA4 NIPBL KDM1A | 9.96e-04 | 562 | 128 | 11 | GO:0003712 |
| GeneOntologyMolecularFunction | histone demethylase activity | 1.01e-03 | 31 | 128 | 3 | GO:0032452 | |
| GeneOntologyMolecularFunction | microtubule motor activity | 1.07e-03 | 70 | 128 | 4 | GO:0003777 | |
| GeneOntologyMolecularFunction | histone H3K4 demethylase activity | 1.11e-03 | 8 | 128 | 2 | GO:0032453 | |
| GeneOntologyMolecularFunction | protein demethylase activity | 1.11e-03 | 32 | 128 | 3 | GO:0140457 | |
| GeneOntologyMolecularFunction | nuclear androgen receptor binding | 1.22e-03 | 33 | 128 | 3 | GO:0050681 | |
| GeneOntologyMolecularFunction | adenylate kinase activity | 1.43e-03 | 9 | 128 | 2 | GO:0004017 | |
| GeneOntologyMolecularFunction | lncRNA binding | 1.45e-03 | 35 | 128 | 3 | GO:0106222 | |
| GeneOntologyMolecularFunction | dynein intermediate chain binding | 1.70e-03 | 37 | 128 | 3 | GO:0045505 | |
| GeneOntologyMolecularFunction | telomeric DNA binding | 2.14e-03 | 40 | 128 | 3 | GO:0042162 | |
| GeneOntologyMolecularFunction | demethylase activity | 2.81e-03 | 44 | 128 | 3 | GO:0032451 | |
| GeneOntologyMolecularFunction | chloride:bicarbonate antiporter activity | 3.04e-03 | 13 | 128 | 2 | GO:0140900 | |
| GeneOntologyMolecularFunction | bicarbonate:monoatomic anion antiporter activity | 3.04e-03 | 13 | 128 | 2 | GO:0140829 | |
| GeneOntologyMolecularFunction | RNA polymerase III general transcription initiation factor activity | 3.04e-03 | 13 | 128 | 2 | GO:0000995 | |
| GeneOntologyBiologicalProcess | chromatin remodeling | SETD1B HDAC6 EP400 KDM4C ANP32B KDM5C KAT6A SRPK2 SMYD5 APP SRCAP LMNB1 ZNF335 CHD5 ATAD2B SMARCA2 EHMT1 SMARCA4 NIPBL KDM1A | 2.05e-08 | 741 | 125 | 20 | GO:0006338 |
| GeneOntologyBiologicalProcess | protein-DNA complex organization | SETD1B HDAC6 EP400 KDM4C ANP32B KDM5C KAT6A SRPK2 SMYD5 APP SRCAP TERF1 LMNB1 ZNF335 CHD5 ATAD2B SMARCA2 EHMT1 SMARCA4 TAF5 NIPBL KDM1A | 1.36e-07 | 999 | 125 | 22 | GO:0071824 |
| GeneOntologyBiologicalProcess | chromatin organization | SETD1B HDAC6 EP400 KDM4C ANP32B KDM5C KAT6A SRPK2 SMYD5 APP SRCAP LMNB1 ZNF335 CHD5 ATAD2B SMARCA2 EHMT1 SMARCA4 NIPBL KDM1A | 4.42e-07 | 896 | 125 | 20 | GO:0006325 |
| GeneOntologyBiologicalProcess | head development | SOX12 DMXL2 ZEB1 RPGRIP1L ANP32B RTN4 KAT6A APLP1 APP AK7 UBE3A ZNF335 CHD5 SKOR2 SMARCA4 SCRIB NIPBL KDM1A | 1.08e-05 | 919 | 125 | 18 | GO:0060322 |
| GeneOntologyBiologicalProcess | androgen receptor signaling pathway | 1.42e-05 | 51 | 125 | 5 | GO:0030521 | |
| GeneOntologyBiologicalProcess | brain development | SOX12 DMXL2 ZEB1 RPGRIP1L ANP32B RTN4 APLP1 APP AK7 UBE3A ZNF335 CHD5 SKOR2 SMARCA4 SCRIB NIPBL KDM1A | 1.71e-05 | 859 | 125 | 17 | GO:0007420 |
| GeneOntologyBiologicalProcess | regulation of relaxation of cardiac muscle | 1.78e-05 | 9 | 125 | 3 | GO:1901897 | |
| GeneOntologyBiologicalProcess | central nervous system development | SOX12 DMXL2 ZEB1 RPGRIP1L ANP32B RTN4 ROR2 APLP1 APP AK7 UBE3A DBX1 ZNF335 CHD5 SKOR2 SMARCA4 IFT122 SCRIB NIPBL KDM1A | 3.37e-05 | 1197 | 125 | 20 | GO:0007417 |
| GeneOntologyBiologicalProcess | regulation of androgen receptor signaling pathway | 3.56e-05 | 31 | 125 | 4 | GO:0060765 | |
| GeneOntologyBiologicalProcess | eye development | NPHP1 CACNA1F ZEB1 RPGRIP1L RP1L1 SMARCA4 CC2D2A IFT122 SCRIB FKBP8 NIPBL ZNF513 | 3.59e-05 | 480 | 125 | 12 | GO:0001654 |
| GeneOntologyBiologicalProcess | positive regulation of relaxation of cardiac muscle | 3.64e-05 | 2 | 125 | 2 | GO:1901899 | |
| GeneOntologyBiologicalProcess | visual system development | NPHP1 CACNA1F ZEB1 RPGRIP1L RP1L1 SMARCA4 CC2D2A IFT122 SCRIB FKBP8 NIPBL ZNF513 | 3.82e-05 | 483 | 125 | 12 | GO:0150063 |
| GeneOntologyBiologicalProcess | sensory system development | NPHP1 CACNA1F ZEB1 RPGRIP1L RP1L1 SMARCA4 CC2D2A IFT122 SCRIB FKBP8 NIPBL ZNF513 | 4.47e-05 | 491 | 125 | 12 | GO:0048880 |
| GeneOntologyBiologicalProcess | tRNA transcription by RNA polymerase III | 4.59e-05 | 12 | 125 | 3 | GO:0042797 | |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection assembly | DNHD1 RAPGEF6 RPGRIP1L HDAC6 RILPL2 CCDC28B RSPH6A AK7 KANK1 RP1L1 DNAI2 CC2D2A IFT122 MAP4K4 | 5.61e-05 | 670 | 125 | 14 | GO:0120031 |
| GeneOntologyBiologicalProcess | camera-type eye development | NPHP1 CACNA1F ZEB1 RPGRIP1L RP1L1 SMARCA4 CC2D2A IFT122 SCRIB FKBP8 ZNF513 | 5.77e-05 | 426 | 125 | 11 | GO:0043010 |
| GeneOntologyBiologicalProcess | tRNA transcription | 5.94e-05 | 13 | 125 | 3 | GO:0009304 | |
| GeneOntologyBiologicalProcess | cell projection assembly | DNHD1 RAPGEF6 RPGRIP1L HDAC6 RILPL2 CCDC28B RSPH6A AK7 KANK1 RP1L1 DNAI2 CC2D2A IFT122 MAP4K4 | 7.11e-05 | 685 | 125 | 14 | GO:0030031 |
| GeneOntologyBiologicalProcess | cilium assembly | DNHD1 RPGRIP1L HDAC6 RILPL2 CCDC28B RSPH6A AK7 RP1L1 DNAI2 CC2D2A IFT122 | 8.34e-05 | 444 | 125 | 11 | GO:0060271 |
| GeneOntologyBiologicalProcess | cellular response to norepinephrine stimulus | 1.09e-04 | 3 | 125 | 2 | GO:0071874 | |
| GeneOntologyBiologicalProcess | sensory organ development | NPHP1 CACNA1F ZEB1 RPGRIP1L ANP32B ROR2 RP1L1 SMARCA4 CC2D2A IFT122 SCRIB FKBP8 NIPBL ZNF513 | 1.39e-04 | 730 | 125 | 14 | GO:0007423 |
| GeneOntologyBiologicalProcess | cilium organization | DNHD1 RPGRIP1L HDAC6 RILPL2 CCDC28B RSPH6A AK7 RP1L1 DNAI2 CC2D2A IFT122 | 1.54e-04 | 476 | 125 | 11 | GO:0044782 |
| GeneOntologyBiologicalProcess | neuron development | NPHP1 CACNA1F RPGRIP1L HDAC6 MAP1B RTN4 ROR2 APLP1 APP NEFM KANK1 UBE3A ZNF335 SKOR2 RP1L1 SCRIB MAP4K4 GOLGA2 KDM1A PICK1 TBCD | 1.83e-04 | 1463 | 125 | 21 | GO:0048666 |
| GeneOntologyBiologicalProcess | epigenetic regulation of gene expression | 1.85e-04 | 330 | 125 | 9 | GO:0040029 | |
| GeneOntologyBiologicalProcess | regulation of relaxation of muscle | 1.96e-04 | 19 | 125 | 3 | GO:1901077 | |
| GeneOntologyBiologicalProcess | microtubule-based movement | DNHD1 HDAC6 DNAH10 MAP1B RSPH6A APP AK7 NEFM DNAI2 IFT122 DNAH11 | 2.08e-04 | 493 | 125 | 11 | GO:0007018 |
| GeneOntologyBiologicalProcess | cytosolic mRNA polyadenylation | 2.17e-04 | 4 | 125 | 2 | GO:0180011 | |
| GeneOntologyBiologicalProcess | microtubule-based process | DNHD1 HDAC6 DNAH10 MAP1B CDK11A RSPH6A APP CCDC88B AK7 NEFM RP1L1 DNAI2 CC2D2A IFT122 GOLGA2 TBCD DNAH11 | 2.21e-04 | 1058 | 125 | 17 | GO:0007017 |
| GeneOntologyBiologicalProcess | microtubule bundle formation | 2.57e-04 | 145 | 125 | 6 | GO:0001578 | |
| GeneOntologyBiologicalProcess | relaxation of cardiac muscle | 2.67e-04 | 21 | 125 | 3 | GO:0055119 | |
| GeneOntologyBiologicalProcess | negative regulation of DNA-templated transcription | SOX12 ZEB1 HDAC6 PHF12 KDM5C KAT6A NACA GON4L PPP1R15A APP SARNP CHD5 SKOR2 SMARCA2 EHMT1 SMARCA4 ZFTA TIMELESS NIPBL KDM1A | 2.81e-04 | 1399 | 125 | 20 | GO:0045892 |
| GeneOntologyBiologicalProcess | regulation of cellular response to stress | HDAC6 EP400 RTN4 PPP1R15A APP TLDC2 SMARCA2 SMARCA4 TIMELESS TAF5 MAP4K4 KDM1A | 2.83e-04 | 598 | 125 | 12 | GO:0080135 |
| GeneOntologyBiologicalProcess | cell morphogenesis | CACNA1F HDAC6 RILPL2 MAP1B RTN4 APLP1 APP NEFM KANK1 UBE3A ZNF335 SKOR2 SMARCA4 SCRIB MAP4K4 GOLGA2 KDM1A TBCD | 3.10e-04 | 1194 | 125 | 18 | GO:0000902 |
| GeneOntologyBiologicalProcess | negative regulation of RNA biosynthetic process | SOX12 ZEB1 HDAC6 PHF12 KDM5C KAT6A NACA GON4L PPP1R15A APP SARNP CHD5 SKOR2 SMARCA2 EHMT1 SMARCA4 ZFTA TIMELESS NIPBL KDM1A | 3.19e-04 | 1413 | 125 | 20 | GO:1902679 |
| GeneOntologyBiologicalProcess | regulation of protein localization to endoplasmic reticulum | 3.60e-04 | 5 | 125 | 2 | GO:1905550 | |
| GeneOntologyBiologicalProcess | positive regulation of relaxation of muscle | 3.60e-04 | 5 | 125 | 2 | GO:1901079 | |
| GeneOntologyBiologicalProcess | response to norepinephrine | 3.60e-04 | 5 | 125 | 2 | GO:0071873 | |
| GeneOntologyBiologicalProcess | cellular component disassembly | HDAC6 MAP1B SHFL VTA1 RSPH6A ATAD2B SMARCA4 ACIN1 MICAL3 FKBP8 MAP4K4 GOLGA2 | 3.75e-04 | 617 | 125 | 12 | GO:0022411 |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection morphogenesis | CACNA1F HDAC6 MAP1B RTN4 APLP1 APP NEFM KANK1 UBE3A ZNF335 SKOR2 MAP4K4 GOLGA2 KDM1A | 4.48e-04 | 819 | 125 | 14 | GO:0120039 |
| GeneOntologyBiologicalProcess | cell projection morphogenesis | CACNA1F HDAC6 MAP1B RTN4 APLP1 APP NEFM KANK1 UBE3A ZNF335 SKOR2 MAP4K4 GOLGA2 KDM1A | 4.87e-04 | 826 | 125 | 14 | GO:0048858 |
| GeneOntologyBiologicalProcess | positive regulation of JNK cascade | 4.90e-04 | 107 | 125 | 5 | GO:0046330 | |
| GeneOntologyBiologicalProcess | organelle assembly | DNHD1 RPGRIP1L HDAC6 RILPL2 CCDC28B VTA1 RSPH6A AK7 MDN1 G3BP1 RP1L1 DNAI2 EIF5B CC2D2A IFT122 TNNT1 GOLGA2 | 5.13e-04 | 1138 | 125 | 17 | GO:0070925 |
| GeneOntologyBiologicalProcess | axoneme assembly | 5.33e-04 | 109 | 125 | 5 | GO:0035082 | |
| GeneOntologyBiologicalProcess | 5S class rRNA transcription by RNA polymerase III | 5.38e-04 | 6 | 125 | 2 | GO:0042791 | |
| GeneOntologyBiologicalProcess | aortic smooth muscle cell differentiation | 5.38e-04 | 6 | 125 | 2 | GO:0035887 | |
| GeneOntologyBiologicalProcess | negative regulation of transcription by RNA polymerase II | SOX12 ZEB1 PHF12 KDM5C NACA PPP1R15A APP SARNP CHD5 SKOR2 SMARCA2 EHMT1 SMARCA4 TIMELESS NIPBL KDM1A | 6.31e-04 | 1053 | 125 | 16 | GO:0000122 |
| GeneOntologyBiologicalProcess | postsynapse organization | 6.51e-04 | 313 | 125 | 8 | GO:0099173 | |
| GeneOntologyBiologicalProcess | intracellular transport | TMED1 RANGAP1 HDAC6 RILPL2 MAP1B ANP32B VTA1 APP SARNP CCDC88B NEFM MDN1 LMNB1 UPF2 EXOC6B HRC IFT122 SCRIB GOLGA2 PICK1 | 6.61e-04 | 1496 | 125 | 20 | GO:0046907 |
| GeneOntologyBiologicalProcess | smoothened signaling pathway | 7.19e-04 | 176 | 125 | 6 | GO:0007224 | |
| GeneOntologyBiologicalProcess | forebrain development | DMXL2 ZEB1 RPGRIP1L RTN4 APLP1 APP ZNF335 CHD5 SMARCA4 KDM1A | 7.98e-04 | 489 | 125 | 10 | GO:0030900 |
| GeneOntologyBiologicalProcess | protein-DNA complex assembly | 8.18e-04 | 249 | 125 | 7 | GO:0065004 | |
| GeneOntologyBiologicalProcess | nucleosome assembly | 8.88e-04 | 122 | 125 | 5 | GO:0006334 | |
| GeneOntologyBiologicalProcess | microtubule-based transport | 8.98e-04 | 253 | 125 | 7 | GO:0099111 | |
| GeneOntologyBiologicalProcess | protein localization to organelle | RANGAP1 RTN4 NACA CHGA PPP1R15A APP TERF1 LMNB1 CCDC47 PES1 CC2D2A IFT122 SCRIB FKBP8 NIPBL DNAH11 | 9.20e-04 | 1091 | 125 | 16 | GO:0033365 |
| GeneOntologyBiologicalProcess | embryonic hemopoiesis | 9.48e-04 | 32 | 125 | 3 | GO:0035162 | |
| GeneOntologyBiologicalProcess | response to fungicide | 9.96e-04 | 8 | 125 | 2 | GO:0060992 | |
| GeneOntologyBiologicalProcess | primitive erythrocyte differentiation | 9.96e-04 | 8 | 125 | 2 | GO:0060319 | |
| GeneOntologyBiologicalProcess | embryo development | ZEB1 RPGRIP1L KDM4C POLE RTN4 ROR2 KAT6A CDK11A CCDC47 ZNF335 EHMT1 SMARCA4 CC2D2A TIMELESS IFT122 SCRIB FKBP8 NIPBL KDM1A | 1.04e-03 | 1437 | 125 | 19 | GO:0009790 |
| GeneOntologyCellularComponent | SWI/SNF superfamily-type complex | 3.15e-05 | 96 | 131 | 6 | GO:0070603 | |
| GeneOntologyCellularComponent | nuclear protein-containing complex | RANGAP1 SETD1B HDAC6 EP400 PHF12 POLE GON4L SRCAP SARNP TERF1 UPF2 POLR3E ZNF335 CHD5 PES1 SMARCA2 SMARCA4 ACIN1 TIMELESS TAF5 NIPBL CCDC9 | 4.42e-05 | 1377 | 131 | 22 | GO:0140513 |
| GeneOntologyCellularComponent | ciliary transition zone | 1.57e-04 | 81 | 131 | 5 | GO:0035869 | |
| GeneOntologyCellularComponent | cilium | NPHP1 DNHD1 CACNA1F RPGRIP1L HDAC6 RILPL2 DNAH10 MAP1B RSPH6A APP AK7 RP1L1 DNAI2 CC2D2A IFT122 DNAH11 | 1.60e-04 | 898 | 131 | 16 | GO:0005929 |
| GeneOntologyCellularComponent | ATPase complex | 1.64e-04 | 129 | 131 | 6 | GO:1904949 | |
| GeneOntologyCellularComponent | plasma membrane bounded cell projection cytoplasm | DNHD1 RANGAP1 RPGRIP1L HDAC6 DNAH10 RSPH6A RP1L1 DNAI2 DNAH11 | 1.77e-04 | 317 | 131 | 9 | GO:0032838 |
| GeneOntologyCellularComponent | histone deacetylase complex | 1.97e-04 | 85 | 131 | 5 | GO:0000118 | |
| GeneOntologyCellularComponent | photoreceptor connecting cilium | 2.31e-04 | 48 | 131 | 4 | GO:0032391 | |
| GeneOntologyCellularComponent | photoreceptor cell cilium | 2.45e-04 | 139 | 131 | 6 | GO:0097733 | |
| GeneOntologyCellularComponent | exon-exon junction complex | 2.95e-04 | 21 | 131 | 3 | GO:0035145 | |
| GeneOntologyCellularComponent | preribosome, large subunit precursor | 2.95e-04 | 21 | 131 | 3 | GO:0030687 | |
| GeneOntologyCellularComponent | axoneme | 3.34e-04 | 207 | 131 | 7 | GO:0005930 | |
| GeneOntologyCellularComponent | ciliary plasm | 3.44e-04 | 208 | 131 | 7 | GO:0097014 | |
| GeneOntologyCellularComponent | dynein complex | 3.65e-04 | 54 | 131 | 4 | GO:0030286 | |
| GeneOntologyCellularComponent | 9+0 non-motile cilium | 4.11e-04 | 153 | 131 | 6 | GO:0097731 | |
| GeneOntologyCellularComponent | cytoplasmic region | DNHD1 RANGAP1 RPGRIP1L HDAC6 DNAH10 RSPH6A RP1L1 DNAI2 DNAH11 | 4.51e-04 | 360 | 131 | 9 | GO:0099568 |
| GeneOntologyCellularComponent | axonemal dynein complex | 5.00e-04 | 25 | 131 | 3 | GO:0005858 | |
| GeneOntologyCellularComponent | microtubule associated complex | 5.38e-04 | 161 | 131 | 6 | GO:0005875 | |
| GeneOntologyCellularComponent | transcription factor TFIIIC complex | 5.75e-04 | 6 | 131 | 2 | GO:0000127 | |
| GeneOntologyCellularComponent | INO80-type complex | 7.03e-04 | 28 | 131 | 3 | GO:0097346 | |
| GeneOntologyCellularComponent | preribosome | 7.61e-04 | 114 | 131 | 5 | GO:0030684 | |
| GeneOntologyCellularComponent | chromatin | SOX12 ZEB1 EP400 CENPB KDM4C PHF12 KDM5C KAT6A GON4L SRPK2 SRCAP DBX1 CHD5 SMARCA2 EHMT1 SMARCA4 TIMELESS TAF5 NIPBL KDM1A | 8.98e-04 | 1480 | 131 | 20 | GO:0000785 |
| GeneOntologyCellularComponent | nuclear chromosome | 1.12e-03 | 254 | 131 | 7 | GO:0000228 | |
| GeneOntologyCellularComponent | RNA polymerase III transcription regulator complex | 1.36e-03 | 9 | 131 | 2 | GO:0090576 | |
| GeneOntologyCellularComponent | neuronal dense core vesicle | 1.48e-03 | 36 | 131 | 3 | GO:0098992 | |
| GeneOntologyCellularComponent | non-motile cilium | 1.49e-03 | 196 | 131 | 6 | GO:0097730 | |
| GeneOntologyCellularComponent | nuclear speck | 1.60e-03 | 431 | 131 | 9 | GO:0016607 | |
| GeneOntologyCellularComponent | nuclear body | SETD1B EP400 CENPB KAT6A GON4L SRPK2 SRCAP SARNP TERF1 VIRMA PRX CHD5 EHMT1 ACIN1 | 1.61e-03 | 903 | 131 | 14 | GO:0016604 |
| GeneOntologyCellularComponent | inner dynein arm | 1.70e-03 | 10 | 131 | 2 | GO:0036156 | |
| GeneOntologyCellularComponent | bBAF complex | 1.70e-03 | 10 | 131 | 2 | GO:0140092 | |
| GeneOntologyCellularComponent | microtubule | RPGRIP1L HDAC6 DNAH10 MAP1B ROR2 RP1L1 DNAI2 GOLGA2 TBCD DNAH11 | 1.96e-03 | 533 | 131 | 10 | GO:0005874 |
| GeneOntologyCellularComponent | perikaryon | 2.85e-03 | 223 | 131 | 6 | GO:0043204 | |
| GeneOntologyCellularComponent | supramolecular fiber | PDE4D RPGRIP1L HDAC6 DNAH10 MAP1B ROR2 STYXL2 NEFM LMNB1 RP1L1 DNAI2 HRC TNNT1 GOLGA2 TBCD DNAH11 | 2.90e-03 | 1179 | 131 | 16 | GO:0099512 |
| GeneOntologyCellularComponent | Swr1 complex | 2.91e-03 | 13 | 131 | 2 | GO:0000812 | |
| GeneOntologyCellularComponent | supramolecular polymer | PDE4D RPGRIP1L HDAC6 DNAH10 MAP1B ROR2 STYXL2 NEFM LMNB1 RP1L1 DNAI2 HRC TNNT1 GOLGA2 TBCD DNAH11 | 3.10e-03 | 1187 | 131 | 16 | GO:0099081 |
| GeneOntologyCellularComponent | npBAF complex | 3.38e-03 | 14 | 131 | 2 | GO:0071564 | |
| GeneOntologyCellularComponent | GBAF complex | 3.38e-03 | 14 | 131 | 2 | GO:0140288 | |
| GeneOntologyCellularComponent | heterochromatin | 3.76e-03 | 101 | 131 | 4 | GO:0000792 | |
| GeneOntologyCellularComponent | preribosome, small subunit precursor | 3.88e-03 | 15 | 131 | 2 | GO:0030688 | |
| GeneOntologyCellularComponent | ciliary rootlet | 4.42e-03 | 16 | 131 | 2 | GO:0035253 | |
| GeneOntologyCellularComponent | nBAF complex | 4.42e-03 | 16 | 131 | 2 | GO:0071565 | |
| GeneOntologyCellularComponent | dense core granule | 5.23e-03 | 56 | 131 | 3 | GO:0031045 | |
| HumanPheno | Abnormal male reproductive system physiology | NPHP1 DNHD1 DMXL2 ZEB1 PDE4D RPGRIP1L DNAH10 CCDC28B POLE KDM5C ROR2 KAT6A SRCAP AK7 LMNB1 RP1L1 DNAI2 SMARCA2 EHMT1 SMARCA4 CC2D2A IFT122 NIPBL KDM1A TBCD ZNF513 DNAH11 | 6.60e-06 | 1314 | 48 | 27 | HP:0012874 |
| HumanPheno | Functional abnormality of male internal genitalia | NPHP1 DNHD1 DMXL2 ZEB1 PDE4D RPGRIP1L DNAH10 CCDC28B POLE KDM5C ROR2 KAT6A SRCAP AK7 RP1L1 DNAI2 SMARCA2 EHMT1 SMARCA4 CC2D2A IFT122 NIPBL KDM1A TBCD ZNF513 DNAH11 | 1.24e-05 | 1269 | 48 | 26 | HP:0000025 |
| HumanPheno | Abnormal calvaria morphology | NPHP1 DMXL2 PDE4D RPGRIP1L SETD1B HDAC6 MAP1B POLE ROR2 KAT6A SRCAP RUSC2 LMNB1 UBE3A CCDC47 CHD5 EXOC6B SMARCA2 EHMT1 CC2D2A IFT122 NIPBL GOLGA2 KDM1A TBCD | 3.57e-05 | 1254 | 48 | 25 | HP:0002683 |
| HumanPheno | Medial flaring of the eyebrow | NPHP1 MAP1B RUSC2 CCDC47 CHD5 SMARCA2 EHMT1 NIPBL KDM1A TBCD | 3.87e-05 | 228 | 48 | 10 | HP:0010747 |
| HumanPheno | Abnormal 5th finger morphology | NPHP1 RPGRIP1L MAP1B CCDC28B ROR2 SRCAP UBE3A CCDC47 SMARCA2 EHMT1 SMARCA4 CC2D2A IFT122 NIPBL KDM1A | 3.87e-05 | 509 | 48 | 15 | HP:0004207 |
| HumanPheno | Language impairment | NPHP1 PDE4D SETD1B MAP1B CCDC28B KDM5C KAT6A APP SRCAP RUSC2 LMNB1 UBE3A CCDC47 CHD5 DNAI2 SMARCA2 EHMT1 SMARCA4 TNNT1 NIPBL GOLGA2 KDM1A TBCD DNAH11 | 4.07e-05 | 1178 | 48 | 24 | HP:0002463 |
| HumanPheno | Tapered finger | 4.18e-05 | 141 | 48 | 8 | HP:0001182 | |
| HumanPheno | Delayed speech and language development | NPHP1 PDE4D SETD1B MAP1B CCDC28B KDM5C KAT6A SRCAP RUSC2 LMNB1 UBE3A CCDC47 CHD5 DNAI2 SMARCA2 EHMT1 SMARCA4 TNNT1 NIPBL GOLGA2 KDM1A TBCD DNAH11 | 6.19e-05 | 1123 | 48 | 23 | HP:0000750 |
| HumanPheno | Synophrys | 6.73e-05 | 195 | 48 | 9 | HP:0000664 | |
| HumanPheno | Abnormal testis morphology | NPHP1 DNHD1 DMXL2 ZEB1 PDE4D RPGRIP1L DNAH10 CCDC28B POLE KDM5C ROR2 KAT6A SRCAP RP1L1 SMARCA2 EHMT1 SMARCA4 CC2D2A IFT122 NIPBL KDM1A TBCD ZNF513 | 6.77e-05 | 1129 | 48 | 23 | HP:0000035 |
| HumanPheno | Non-obstructive azoospermia | NPHP1 DNHD1 DMXL2 ZEB1 PDE4D RPGRIP1L DNAH10 CCDC28B POLE KDM5C ROR2 KAT6A SRCAP RP1L1 SMARCA2 EHMT1 SMARCA4 CC2D2A IFT122 NIPBL KDM1A TBCD ZNF513 | 7.07e-05 | 1132 | 48 | 23 | HP:0011961 |
| HumanPheno | Abnormality of calvarial morphology | NPHP1 DMXL2 PDE4D RPGRIP1L SETD1B HDAC6 POLE ROR2 KAT6A RUSC2 LMNB1 UBE3A CCDC47 CHD5 EXOC6B SMARCA2 EHMT1 CC2D2A IFT122 NIPBL GOLGA2 KDM1A TBCD | 7.28e-05 | 1134 | 48 | 23 | HP:0002648 |
| HumanPheno | Aplasia/Hypoplasia involving bones of the feet | PDE4D HDAC6 CCDC28B KDM5C ROR2 KAT6A CCDC47 SMARCA2 SMARCA4 IFT122 NIPBL | 7.35e-05 | 298 | 48 | 11 | HP:0006494 |
| HumanPheno | Hypertrichosis | NPHP1 MAP1B CCDC28B SRCAP RUSC2 CCDC47 CHD5 SMARCA2 EHMT1 SMARCA4 NIPBL KDM1A TBCD | 1.01e-04 | 425 | 48 | 13 | HP:0000998 |
| HumanPheno | Azoospermia | NPHP1 DNHD1 DMXL2 ZEB1 PDE4D RPGRIP1L DNAH10 CCDC28B POLE KDM5C ROR2 KAT6A SRCAP RP1L1 SMARCA2 EHMT1 SMARCA4 CC2D2A IFT122 NIPBL KDM1A TBCD ZNF513 | 1.01e-04 | 1157 | 48 | 23 | HP:0000027 |
| HumanPheno | Highly arched eyebrow | 1.03e-04 | 206 | 48 | 9 | HP:0002553 | |
| HumanPheno | Facial hypertrichosis | 1.03e-04 | 206 | 48 | 9 | HP:0002219 | |
| HumanPheno | Widely spaced teeth | 1.44e-04 | 125 | 48 | 7 | HP:0000687 | |
| HumanPheno | Abnormality of teeth spacing | 1.60e-04 | 127 | 48 | 7 | HP:0006478 | |
| HumanPheno | Abnormal spermatogenesis | NPHP1 DNHD1 DMXL2 ZEB1 PDE4D RPGRIP1L DNAH10 CCDC28B POLE KDM5C ROR2 KAT6A SRCAP RP1L1 SMARCA2 EHMT1 SMARCA4 CC2D2A IFT122 NIPBL KDM1A TBCD ZNF513 | 1.60e-04 | 1190 | 48 | 23 | HP:0008669 |
| HumanPheno | Long eyelashes | 1.76e-04 | 129 | 48 | 7 | HP:0000527 | |
| HumanPheno | Scoliosis | NPHP1 PDE4D RPGRIP1L MAP1B CCDC28B POLE ROR2 AK9 SRCAP PRX RUSC2 LMNB1 UBE3A CCDC47 EXOC6B SMARCA2 EHMT1 SMARCA4 CC2D2A MAPKBP1 TNNT1 TBCD | 2.00e-04 | 1122 | 48 | 22 | HP:0002650 |
| HumanPheno | Enlarged joints | 2.10e-04 | 13 | 48 | 3 | HP:0003037 | |
| HumanPheno | Abnormal eyebrow morphology | NPHP1 RPGRIP1L SETD1B MAP1B KDM5C KAT6A RUSC2 CCDC47 CHD5 SMARCA2 EHMT1 SMARCA4 CC2D2A NIPBL KDM1A TBCD | 2.72e-04 | 674 | 48 | 16 | HP:0000534 |
| HumanPheno | Posteriorly rotated ears | NPHP1 PDE4D RPGRIP1L MAP1B POLE ROR2 KAT6A SRCAP RUSC2 CHD5 SMARCA2 CC2D2A NIPBL | 2.80e-04 | 470 | 48 | 13 | HP:0000358 |
| HumanPheno | Autistic behavior | NPHP1 DMXL2 PDE4D RPGRIP1L SETD1B MAP1B KDM5C KAT6A SRCAP UBE3A CHD5 SMARCA2 EHMT1 SMARCA4 CC2D2A NIPBL | 2.92e-04 | 678 | 48 | 16 | HP:0000729 |
| HumanPheno | Abnormal male external genitalia morphology | NPHP1 DNHD1 DMXL2 ZEB1 PDE4D RPGRIP1L DNAH10 CCDC28B POLE KDM5C ROR2 KAT6A SRCAP LMNB1 RP1L1 SMARCA2 EHMT1 SMARCA4 CC2D2A IFT122 NIPBL KDM1A TBCD ZNF513 | 3.13e-04 | 1329 | 48 | 24 | HP:0000032 |
| HumanPheno | Prominent nasal bridge | 3.19e-04 | 239 | 48 | 9 | HP:0000426 | |
| HumanPheno | Abnormal male internal genitalia morphology | NPHP1 DNHD1 DMXL2 ZEB1 PDE4D RPGRIP1L DNAH10 CCDC28B POLE KDM5C ROR2 KAT6A SRCAP RP1L1 SMARCA2 EHMT1 SMARCA4 CC2D2A IFT122 NIPBL KDM1A TBCD ZNF513 | 3.20e-04 | 1243 | 48 | 23 | HP:0000022 |
| HumanPheno | Abnormal external nose morphology | NPHP1 DMXL2 PDE4D RPGRIP1L HDAC6 ROR2 KAT6A SRCAP RUSC2 CCDC47 CHD5 SMARCA2 EHMT1 SMARCA4 CC2D2A IFT122 NIPBL KDM1A TBCD | 3.44e-04 | 916 | 48 | 19 | HP:0010938 |
| HumanPheno | Abnormal hand morphology | NPHP1 DMXL2 PDE4D RPGRIP1L HDAC6 MAP1B CCDC28B KDM5C ROR2 SRCAP PRX UBE3A CCDC47 EXOC6B SMARCA2 EHMT1 SMARCA4 CC2D2A IFT122 NIPBL KDM1A | 3.61e-04 | 1082 | 48 | 21 | HP:0005922 |
| HumanPheno | Tooth malposition | NPHP1 PDE4D CCDC28B KDM5C ROR2 UBE3A CCDC47 SMARCA2 IFT122 NIPBL KDM1A TBCD | 3.62e-04 | 418 | 48 | 12 | HP:0000692 |
| HumanPheno | Joint hypermobility | NPHP1 PDE4D MAP1B ROR2 SRCAP RUSC2 UBE3A CCDC47 EXOC6B SMARCA2 EHMT1 SMARCA4 IFT122 KDM1A | 4.18e-04 | 557 | 48 | 14 | HP:0001382 |
| HumanPheno | Anteverted nares | NPHP1 DMXL2 PDE4D RPGRIP1L ROR2 KAT6A SRCAP SMARCA2 EHMT1 SMARCA4 CC2D2A IFT122 NIPBL KDM1A | 4.34e-04 | 559 | 48 | 14 | HP:0000463 |
| HumanPheno | Upturned nose | NPHP1 DMXL2 PDE4D RPGRIP1L ROR2 KAT6A SRCAP SMARCA2 EHMT1 SMARCA4 CC2D2A IFT122 NIPBL KDM1A | 4.34e-04 | 559 | 48 | 14 | HP:0000427 |
| HumanPheno | Abnormal external genitalia | NPHP1 DNHD1 DMXL2 ZEB1 PDE4D RPGRIP1L DNAH10 CCDC28B POLE KDM5C ROR2 KAT6A SRCAP LMNB1 RP1L1 SMARCA2 EHMT1 SMARCA4 CC2D2A IFT122 NIPBL KDM1A TBCD ZNF513 | 5.24e-04 | 1372 | 48 | 24 | HP:0000811 |
| HumanPheno | Clinodactyly | NPHP1 MAP1B POLE KDM5C ROR2 SRCAP UBE3A CCDC47 SMARCA2 EHMT1 SMARCA4 IFT122 NIPBL KDM1A | 5.70e-04 | 574 | 48 | 14 | HP:0030084 |
| HumanPheno | Abnormal nostril morphology | NPHP1 DMXL2 PDE4D RPGRIP1L ROR2 KAT6A SRCAP SMARCA2 EHMT1 SMARCA4 CC2D2A IFT122 NIPBL KDM1A | 5.80e-04 | 575 | 48 | 14 | HP:0005288 |
| HumanPheno | Abnormality of the forehead | DMXL2 PDE4D RPGRIP1L HDAC6 MAP1B POLE KDM5C ROR2 KAT6A SRCAP LMNB1 CCDC47 ZNF335 CHD5 SMARCA2 SMARCA4 CC2D2A IFT122 NIPBL GOLGA2 KDM1A TBCD | 6.09e-04 | 1208 | 48 | 22 | HP:0000290 |
| HumanPheno | Abnormal finger morphology | NPHP1 DMXL2 PDE4D RPGRIP1L SETD1B MAP1B CCDC28B KDM5C ROR2 KAT6A SRCAP RUSC2 UBE3A CCDC47 DNAI2 EXOC6B SMARCA2 EHMT1 SMARCA4 CC2D2A IFT122 NIPBL KDM1A DNAH11 | 6.09e-04 | 1385 | 48 | 24 | HP:0001167 |
| HumanPheno | Radial deviation of finger | NPHP1 MAP1B CCDC28B ROR2 SRCAP UBE3A CCDC47 SMARCA2 EHMT1 IFT122 NIPBL KDM1A | 6.83e-04 | 448 | 48 | 12 | HP:0009466 |
| HumanPheno | Abnormal curvature of the vertebral column | NPHP1 PDE4D RPGRIP1L MAP1B CCDC28B POLE ROR2 AK9 SRCAP PRX RUSC2 LMNB1 UBE3A CCDC47 EXOC6B SMARCA2 EHMT1 SMARCA4 CC2D2A MAPKBP1 TNNT1 TBCD | 6.96e-04 | 1219 | 48 | 22 | HP:0010674 |
| HumanPheno | Short finger | DMXL2 PDE4D KDM5C ROR2 SRCAP SMARCA2 SMARCA4 IFT122 NIPBL KDM1A | 7.20e-04 | 325 | 48 | 10 | HP:0009381 |
| HumanPheno | Hirsutism | 7.99e-04 | 216 | 48 | 8 | HP:0001007 | |
| HumanPheno | Radial deviation of the hand or of fingers of the hand | NPHP1 MAP1B CCDC28B ROR2 SRCAP UBE3A CCDC47 SMARCA2 EHMT1 IFT122 NIPBL KDM1A | 8.01e-04 | 456 | 48 | 12 | HP:0009485 |
| HumanPheno | Astigmatism | 8.23e-04 | 217 | 48 | 8 | HP:0000483 | |
| HumanPheno | Sparse medial eyebrow | 8.54e-04 | 5 | 48 | 2 | HP:0025325 | |
| HumanPheno | Diagnostic behavioral phenotype | NPHP1 DMXL2 PDE4D RPGRIP1L SETD1B MAP1B KDM5C KAT6A SRCAP UBE3A CHD5 SMARCA2 EHMT1 SMARCA4 CC2D2A NIPBL | 8.82e-04 | 747 | 48 | 16 | HP:0025783 |
| HumanPheno | Macrostomia | 9.01e-04 | 220 | 48 | 8 | HP:0000181 | |
| HumanPheno | Wide mouth | 9.01e-04 | 220 | 48 | 8 | HP:0000154 | |
| HumanPheno | Abnormality of the curvature of the cornea | NPHP1 CACNA1F ZEB1 CCDC28B KAT6A CCDC47 RP1L1 CC2D2A NIPBL ZNF513 | 9.33e-04 | 336 | 48 | 10 | HP:0100691 |
| HumanPheno | Abnormality of upper lip vermillion | PDE4D MAP1B KDM5C ROR2 KAT6A SRCAP SMARCA2 EHMT1 SMARCA4 NIPBL GOLGA2 KDM1A | 9.36e-04 | 464 | 48 | 12 | HP:0011339 |
| HumanPheno | Abnormal hair morphology | NPHP1 DMXL2 PDE4D RPGRIP1L SETD1B MAP1B CCDC28B KDM5C ROR2 KAT6A SRCAP RUSC2 LMNB1 UBE3A CCDC47 CHD5 SMARCA2 EHMT1 SMARCA4 CC2D2A IFT122 NIPBL KDM1A TBCD | 9.43e-04 | 1424 | 48 | 24 | HP:0001595 |
| HumanPheno | Strabismus | NPHP1 CACNA1F DMXL2 ZEB1 PDE4D RPGRIP1L CCDC28B KDM5C ROR2 KAT6A SRCAP LMNB1 UBE3A RP1L1 EHMT1 SMARCA4 CC2D2A NIPBL GOLGA2 KDM1A TBCD | 9.56e-04 | 1159 | 48 | 21 | HP:0000486 |
| Domain | HSA | 2.31e-09 | 4 | 131 | 4 | SM00573 | |
| Domain | HSA | 2.31e-09 | 4 | 131 | 4 | PS51204 | |
| Domain | HSA_dom | 2.31e-09 | 4 | 131 | 4 | IPR014012 | |
| Domain | HSA | 2.31e-09 | 4 | 131 | 4 | PF07529 | |
| Domain | SNF2_N | 2.72e-06 | 32 | 131 | 5 | IPR000330 | |
| Domain | SNF2_N | 2.72e-06 | 32 | 131 | 5 | PF00176 | |
| Domain | Gln-Leu-Gln_QLQ | 4.88e-05 | 2 | 131 | 2 | IPR014978 | |
| Domain | SnAC | 4.88e-05 | 2 | 131 | 2 | PF14619 | |
| Domain | QLQ | 4.88e-05 | 2 | 131 | 2 | SM00951 | |
| Domain | QLQ | 4.88e-05 | 2 | 131 | 2 | PS51666 | |
| Domain | SnAC | 4.88e-05 | 2 | 131 | 2 | SM01314 | |
| Domain | SnAC | 4.88e-05 | 2 | 131 | 2 | IPR029295 | |
| Domain | QLQ | 4.88e-05 | 2 | 131 | 2 | PF08880 | |
| Domain | Dynein_HC_stalk | 1.16e-04 | 14 | 131 | 3 | IPR024743 | |
| Domain | Dynein_heavy_dom-2 | 1.16e-04 | 14 | 131 | 3 | IPR013602 | |
| Domain | DHC_N2 | 1.16e-04 | 14 | 131 | 3 | PF08393 | |
| Domain | ATPase_dyneun-rel_AAA | 1.16e-04 | 14 | 131 | 3 | IPR011704 | |
| Domain | MT | 1.16e-04 | 14 | 131 | 3 | PF12777 | |
| Domain | AAA_5 | 1.16e-04 | 14 | 131 | 3 | PF07728 | |
| Domain | DHC_fam | 1.44e-04 | 15 | 131 | 3 | IPR026983 | |
| Domain | Dynein_heavy | 1.44e-04 | 15 | 131 | 3 | PF03028 | |
| Domain | Dynein_heavy_dom | 1.44e-04 | 15 | 131 | 3 | IPR004273 | |
| Domain | Amyloid_glyco_E2_domain | 1.46e-04 | 3 | 131 | 2 | IPR024329 | |
| Domain | A4_EXTRA | 1.46e-04 | 3 | 131 | 2 | PS00319 | |
| Domain | Amyloid_glyco_heparin-bd | 1.46e-04 | 3 | 131 | 2 | IPR015849 | |
| Domain | A4_INTRA | 1.46e-04 | 3 | 131 | 2 | PS00320 | |
| Domain | - | 1.46e-04 | 3 | 131 | 2 | 3.90.570.10 | |
| Domain | Anion_exchange_CS | 1.46e-04 | 3 | 131 | 2 | IPR018241 | |
| Domain | APP_N | 1.46e-04 | 3 | 131 | 2 | PF02177 | |
| Domain | APP_Cu_bd | 1.46e-04 | 3 | 131 | 2 | PF12924 | |
| Domain | APP_E2 | 1.46e-04 | 3 | 131 | 2 | PF12925 | |
| Domain | APP_amyloid | 1.46e-04 | 3 | 131 | 2 | PF10515 | |
| Domain | Amyloid_glyco | 1.46e-04 | 3 | 131 | 2 | IPR008155 | |
| Domain | Amyloid_glyco_extra | 1.46e-04 | 3 | 131 | 2 | IPR008154 | |
| Domain | - | 1.46e-04 | 3 | 131 | 2 | 3.30.1490.140 | |
| Domain | APP_amyloid_C | 1.46e-04 | 3 | 131 | 2 | IPR019543 | |
| Domain | Amyloid_glyco_extracell_CS | 1.46e-04 | 3 | 131 | 2 | IPR019744 | |
| Domain | Amyloid_glyco_intracell_CS | 1.46e-04 | 3 | 131 | 2 | IPR019745 | |
| Domain | Amyloid_glyco_Cu-bd | 1.46e-04 | 3 | 131 | 2 | IPR011178 | |
| Domain | A4_EXTRA | 1.46e-04 | 3 | 131 | 2 | SM00006 | |
| Domain | - | DNHD1 EP400 DNAH10 AK9 SRCAP AK7 MDN1 CHD5 ATAD2B SMARCA2 SMARCA4 EIF5B GNL1 DNAH11 TJP3 | 2.36e-04 | 746 | 131 | 15 | 3.40.50.300 |
| Domain | P-loop_NTPase | DNHD1 EP400 DNAH10 AK9 SRCAP AK7 MYO15B MDN1 CHD5 ATAD2B SMARCA2 SMARCA4 EIF5B GNL1 DNAH11 TJP3 | 2.96e-04 | 848 | 131 | 16 | IPR027417 |
| Domain | PHD | 4.07e-04 | 89 | 131 | 5 | SM00249 | |
| Domain | Znf_PHD | 4.51e-04 | 91 | 131 | 5 | IPR001965 | |
| Domain | Anion_exchange | 4.82e-04 | 5 | 131 | 2 | IPR001717 | |
| Domain | ZF_PHD_2 | 5.50e-04 | 95 | 131 | 5 | PS50016 | |
| Domain | ZF_PHD_1 | 5.77e-04 | 96 | 131 | 5 | PS01359 | |
| Domain | BRK | 7.19e-04 | 6 | 131 | 2 | SM00592 | |
| Domain | BRK_domain | 7.19e-04 | 6 | 131 | 2 | IPR006576 | |
| Domain | Myb-like_dom | 7.19e-04 | 6 | 131 | 2 | IPR017877 | |
| Domain | BRK | 7.19e-04 | 6 | 131 | 2 | PF07533 | |
| Domain | Bromodomain_CS | 7.79e-04 | 26 | 131 | 3 | IPR018359 | |
| Domain | Helicase_C | 9.44e-04 | 107 | 131 | 5 | PF00271 | |
| Domain | HELICc | 9.44e-04 | 107 | 131 | 5 | SM00490 | |
| Domain | Helicase_C | 9.84e-04 | 108 | 131 | 5 | IPR001650 | |
| Domain | ANION_EXCHANGER_2 | 1.00e-03 | 7 | 131 | 2 | PS00220 | |
| Domain | ANION_EXCHANGER_1 | 1.00e-03 | 7 | 131 | 2 | PS00219 | |
| Domain | HELICASE_CTER | 1.03e-03 | 109 | 131 | 5 | PS51194 | |
| Domain | HELICASE_ATP_BIND_1 | 1.03e-03 | 109 | 131 | 5 | PS51192 | |
| Domain | DEXDc | 1.03e-03 | 109 | 131 | 5 | SM00487 | |
| Domain | Helicase_ATP-bd | 1.07e-03 | 110 | 131 | 5 | IPR014001 | |
| Domain | DHC_N1 | 1.33e-03 | 8 | 131 | 2 | PF08385 | |
| Domain | Dynein_heavy_dom-1 | 1.33e-03 | 8 | 131 | 2 | IPR013594 | |
| Domain | - | 1.70e-03 | 9 | 131 | 2 | 3.40.1100.10 | |
| Domain | Band3_cytoplasmic_dom | 1.70e-03 | 9 | 131 | 2 | IPR013769 | |
| Domain | Band_3_cyto | 1.70e-03 | 9 | 131 | 2 | PF07565 | |
| Domain | DUF1220 | 1.70e-03 | 9 | 131 | 2 | SM01148 | |
| Domain | PHD | 1.91e-03 | 75 | 131 | 4 | PF00628 | |
| Domain | JmjN | 2.12e-03 | 10 | 131 | 2 | SM00545 | |
| Domain | JmjN | 2.12e-03 | 10 | 131 | 2 | PF02375 | |
| Domain | PTrfase/Anion_transptr | 2.12e-03 | 10 | 131 | 2 | IPR016152 | |
| Domain | HCO3_transpt_euk | 2.12e-03 | 10 | 131 | 2 | IPR003020 | |
| Domain | HCO3_cotransp | 2.12e-03 | 10 | 131 | 2 | PF00955 | |
| Domain | HCO3_transpt_C | 2.12e-03 | 10 | 131 | 2 | IPR011531 | |
| Domain | JMJN | 2.12e-03 | 10 | 131 | 2 | PS51183 | |
| Domain | Adenylat/UMP-CMP_kin | 2.12e-03 | 10 | 131 | 2 | IPR000850 | |
| Domain | JmjN | 2.12e-03 | 10 | 131 | 2 | IPR003349 | |
| Domain | BROMODOMAIN_1 | 2.20e-03 | 37 | 131 | 3 | PS00633 | |
| Domain | Znf_PHD-finger | 2.31e-03 | 79 | 131 | 4 | IPR019787 | |
| Domain | WD40 | 2.36e-03 | 259 | 131 | 7 | PF00400 | |
| Domain | Bromodomain | 2.38e-03 | 38 | 131 | 3 | PF00439 | |
| Domain | MYB_LIKE | 2.38e-03 | 38 | 131 | 3 | PS50090 | |
| Domain | DUF1220 | 2.58e-03 | 11 | 131 | 2 | PF06758 | |
| Domain | NBPF_dom | 2.58e-03 | 11 | 131 | 2 | IPR010630 | |
| Domain | NBPF | 2.58e-03 | 11 | 131 | 2 | PS51316 | |
| Domain | WD40 | 2.86e-03 | 268 | 131 | 7 | SM00320 | |
| Domain | SET | 2.96e-03 | 41 | 131 | 3 | PF00856 | |
| Domain | BROMODOMAIN_2 | 2.96e-03 | 41 | 131 | 3 | PS50014 | |
| Domain | WD40_repeat | 3.10e-03 | 272 | 131 | 7 | IPR001680 | |
| Domain | SH3_2 | 3.15e-03 | 86 | 131 | 4 | PF07653 | |
| Domain | SH3_2 | 3.15e-03 | 86 | 131 | 4 | IPR011511 | |
| Domain | Bromodomain | 3.17e-03 | 42 | 131 | 3 | IPR001487 | |
| Domain | BROMO | 3.17e-03 | 42 | 131 | 3 | SM00297 | |
| Domain | - | 3.17e-03 | 42 | 131 | 3 | 1.20.920.10 | |
| Domain | PDZ | 3.18e-03 | 141 | 131 | 5 | PF00595 | |
| Domain | AAA | 3.48e-03 | 144 | 131 | 5 | SM00382 | |
| Domain | AAA+_ATPase | 3.48e-03 | 144 | 131 | 5 | IPR003593 | |
| Domain | WD_REPEATS_2 | 3.56e-03 | 279 | 131 | 7 | PS50082 | |
| Domain | WD_REPEATS_REGION | 3.56e-03 | 279 | 131 | 7 | PS50294 | |
| Domain | Znf_FYVE_PHD | 3.80e-03 | 147 | 131 | 5 | IPR011011 | |
| Pathway | WP_CILIOPATHIES | 2.82e-06 | 184 | 91 | 9 | M39880 | |
| Pathway | REACTOME_CHROMATIN_MODIFYING_ENZYMES | 6.39e-05 | 272 | 91 | 9 | M29619 | |
| Pathway | REACTOME_CHROMATIN_MODIFYING_ENZYMES | 1.36e-04 | 175 | 91 | 7 | MM14941 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | RANGAP1 ZEB1 RAPGEF6 HDAC6 EP400 PHF12 KDM5C CDK11A VIRMA ESF1 SCAF1 MDN1 G3BP1 ZNF335 SMARCA2 SMARCA4 EIF5B ACIN1 UTP20 MICAL3 TIMELESS SCRIB MAP4K4 NIPBL CCDC9 | 3.61e-16 | 774 | 135 | 25 | 15302935 |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | RANGAP1 ILF2 SETD1B HDAC6 EP400 MAP1B POLE NACA NOB1 ZNF185 VTA1 SRCAP GTF3C3 ESF1 MDN1 GTF3C2 LMNB1 G3BP1 UPF2 UBE3A CCDC47 PES1 SMARCA2 SMARCA4 EIF5B ACIN1 UTP20 SCRIB NIPBL KDM1A | 6.70e-15 | 1353 | 135 | 30 | 29467282 |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | DNHD1 RANGAP1 ILF2 DNAH10 ANP32B POLE RTN4 NACA RBM26 GTF3C3 ESF1 SCAF1 MDN1 GTF3C2 LMNB1 G3BP1 CCDC47 PES1 EHMT1 SMARCA4 EIF5B ACIN1 CC2D2A UTP20 MAP4K4 NIPBL KDM1A | 7.12e-12 | 1425 | 135 | 27 | 30948266 |
| Pubmed | ILF2 EP400 CENPB ANP32B POLE KDM5C RBM26 SMYD5 SARNP VIRMA GTF3C3 ESF1 MDN1 GTF3C2 UBE3A PES1 SMARCA2 EHMT1 SMARCA4 EIF5B ACIN1 NIPBL KDM1A | 9.09e-12 | 1014 | 135 | 23 | 32416067 | |
| Pubmed | DMXL2 RAPGEF6 MAP1B POLE RTN4 NACA GON4L SRPK2 ESF1 SLC4A2 RUSC2 UPF2 MICAL3 TIMELESS IFT122 SCRIB FKBP8 MAP4K4 GOLGA2 | 9.68e-12 | 650 | 135 | 19 | 38777146 | |
| Pubmed | RANGAP1 ILF2 MAP1B POLE VIRMA GTF3C3 ESF1 NEFM MDN1 G3BP1 ATAD2B PES1 SMARCA2 SMARCA4 EIF5B ACIN1 UTP20 NIPBL KDM1A | 1.05e-11 | 653 | 135 | 19 | 22586326 | |
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | ILF2 CENPB MAP1B POLE KAT6A NACA ZNF622 SRPK2 SARNP TERF1 VIRMA GTF3C3 ESF1 MDN1 GTF3C2 G3BP1 UPF2 SMARCA4 ACIN1 UTP20 | 1.69e-11 | 759 | 135 | 20 | 35915203 |
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | TMED1 RANGAP1 HDAC6 EP400 CENPB MAP1B POLE KDM5C RBM26 CDK11A SRPK2 GTF3C3 NEFM MDN1 GTF3C2 PES1 SMARCA4 EIF5B UTP20 SCRIB KDM1A | 1.94e-11 | 857 | 135 | 21 | 25609649 |
| Pubmed | KAP1 facilitates reinstatement of heterochromatin after DNA replication. | RANGAP1 ILF2 MAP1B POLE ZNF622 VTA1 VIRMA UPF2 UBE3A CCDC47 PES1 SMARCA2 EHMT1 SMARCA4 UTP20 TIMELESS SCRIB NIPBL KDM1A | 3.78e-11 | 704 | 135 | 19 | 29955894 |
| Pubmed | RANGAP1 RAPGEF6 EP400 MAP1B RBM26 SRCAP GTF3C3 ESF1 NEFM GTF3C2 LMNB1 SMARCA4 ACIN1 SCRIB TAF5 MAP4K4 KDM1A | 5.32e-11 | 549 | 135 | 17 | 38280479 | |
| Pubmed | ZMYM3 regulates BRCA1 localization at damaged chromatin to promote DNA repair. | RANGAP1 EP400 CENPB GON4L SRCAP GTF3C3 MDN1 SMARCA4 NIPBL KDM1A | 4.09e-10 | 150 | 135 | 10 | 28242625 |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | RANGAP1 ILF2 EP400 MAP1B NACA APP SRCAP SCAF1 MDN1 LMNB1 G3BP1 PES1 SMARCA4 EIF5B ACIN1 UTP20 SCRIB FKBP8 MAP4K4 NIPBL KDM1A | 4.99e-10 | 1024 | 135 | 21 | 24711643 |
| Pubmed | DMXL2 RANGAP1 ILF2 ANP32B POLE RTN4 ROR2 ZNF622 SRPK2 APP GTF3C3 ESF1 SLC4A2 MDN1 GTF3C2 LMNB1 CCDC47 PES1 EHMT1 EIF5B IFT122 SCRIB FKBP8 MAP4K4 ENSA | 5.77e-10 | 1487 | 135 | 25 | 33957083 | |
| Pubmed | SETD1B HDAC6 EP400 KDM4C KDM5C KAT6A SRCAP SMARCA2 EHMT1 SMARCA4 | 6.39e-10 | 157 | 135 | 10 | 30186101 | |
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | RANGAP1 PDE4D HDAC6 NACA GTF3C3 PTMS KANK1 GTF3C2 LMNB1 SMARCA2 EHMT1 SMARCA4 PPME1 MICAL3 TIMELESS SCRIB GNL1 NIPBL CCDC9 GOLGA2 KDM1A TBCD | 7.29e-10 | 1155 | 135 | 22 | 20360068 |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | RAPGEF6 SETD1B EP400 PHF12 POLE KAT6A NOB1 ZNF316 SRCAP NBPF1 SCAF1 MDN1 ZNF335 CHD5 EHMT1 MICAL3 MAPKBP1 RGL2 PICK1 TBCD TJP3 | 1.93e-09 | 1105 | 135 | 21 | 35748872 |
| Pubmed | EP400 PHF12 NACA RBM26 ZNF622 GON4L CDK11A SRPK2 APP VIRMA ESF1 SCAF1 MDN1 GTF3C2 CCDC47 PES1 SMARCA2 EHMT1 EIF5B UTP20 FKBP8 TAF5 NIPBL KDM1A | 3.39e-09 | 1497 | 135 | 24 | 31527615 | |
| Pubmed | TMED1 RANGAP1 MAP1B NACA NOB1 RBM26 ZNF622 GON4L SRPK2 GTF3C3 ESF1 GTF3C2 CCDC47 PES1 FKBP8 | 4.01e-09 | 547 | 135 | 15 | 37267103 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | RANGAP1 RAPGEF6 EP400 MAP1B RTN4 NACA RBM26 ZNF622 SRCAP ESF1 G3BP1 PES1 SMARCA4 EIF5B PPME1 ACIN1 SCRIB NIPBL ENSA | 4.12e-09 | 934 | 135 | 19 | 33916271 |
| Pubmed | 4.28e-09 | 191 | 135 | 10 | 20195357 | ||
| Pubmed | DMXL2 RANGAP1 ZEB1 ILF2 SRPK2 VIRMA NEFM MDN1 LMNB1 G3BP1 UBE3A EHMT1 SMARCA4 SCRIB TAF5 MAP4K4 NIPBL GOLGA2 KDM1A | 6.75e-09 | 963 | 135 | 19 | 28671696 | |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | DMXL2 RANGAP1 ILF2 HDAC6 EP400 MAP1B SRCAP SARNP TERF1 GTF3C3 NEFM LMNB1 UPF2 PES1 EHMT1 SMARCA4 EIF5B ACIN1 MAP4K4 NIPBL | 7.77e-09 | 1082 | 135 | 20 | 38697112 |
| Pubmed | PTENα and PTENβ promote carcinogenesis through WDR5 and H3K4 trimethylation. | RANGAP1 ILF2 NACA GTF3C3 MDN1 GTF3C2 LMNB1 CCDC47 SMARCA4 KDM1A | 1.45e-08 | 217 | 135 | 10 | 31685992 |
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | SETD1B EP400 SRPK2 SRCAP SARNP GTF3C3 ESF1 GTF3C2 G3BP1 SMARCA2 SMARCA4 SCRIB KDM1A | 1.93e-08 | 440 | 135 | 13 | 34244565 |
| Pubmed | TMED1 ZEB1 ILF2 EP400 DNAH10 PHF12 NACA GON4L CDK11A SRCAP GTF3C3 PTMS GTF3C2 G3BP1 CHD5 PES1 SMARCA2 EHMT1 SMARCA4 TAF5 NIPBL KDM1A | 3.41e-08 | 1429 | 135 | 22 | 35140242 | |
| Pubmed | CENPB NOB1 ZNF622 SRPK2 GTF3C3 SCAF1 MDN1 PES1 SMARCA4 EIF5B | 5.73e-08 | 251 | 135 | 10 | 28077445 | |
| Pubmed | HDAC6 EP400 CENPB PHF12 KDM5C KAT6A ZNF316 SRPK2 APP SRCAP SCAF1 CHD5 SMARCA2 EHMT1 SMARCA4 SCRIB FKBP8 TAF5 KDM1A | 6.95e-08 | 1116 | 135 | 19 | 31753913 | |
| Pubmed | The Tumor Suppressor CIC Directly Regulates MAPK Pathway Genes via Histone Deacetylation. | RANGAP1 EP400 PHF12 POLE GTF3C3 GTF3C2 LMNB1 POLR3E EHMT1 SMARCA4 ACIN1 SCRIB TAF5 KDM1A | 7.05e-08 | 583 | 135 | 14 | 29844126 |
| Pubmed | CENPB KAT6A NOB1 ZNF622 SRPK2 TERF1 ESF1 SCAF1 GTF3C2 CCDC47 SMARCA4 TAF5 | 9.25e-08 | 417 | 135 | 12 | 36537216 | |
| Pubmed | 9.43e-08 | 57 | 135 | 6 | 18022353 | ||
| Pubmed | DMXL2 KCNH8 SETD1B DNAH10 KAT6A CDK11A SRPK2 CAPN8 SMARCA2 EHMT1 SMARCA4 TAF5 ENSA KDM1A DNAH11 | 1.76e-07 | 730 | 135 | 15 | 34857952 | |
| Pubmed | PHF12 POLE NOB1 VIRMA ESF1 PTMS NBPF15 MDN1 UBE3A CCDC47 SMARCA2 EHMT1 NIPBL DNAH11 | 2.11e-07 | 638 | 135 | 14 | 31182584 | |
| Pubmed | 2.33e-07 | 222 | 135 | 9 | 37071664 | ||
| Pubmed | Protein interactome reveals converging molecular pathways among autism disorders. | PHF12 RBM26 APP CCDC88B RUSC2 NBPF15 UBE3A SMARCA2 FKBP8 MAPKBP1 ENSA GOLGA2 PICK1 | 3.11e-07 | 560 | 135 | 13 | 21653829 |
| Pubmed | 3.72e-07 | 116 | 135 | 7 | 21549307 | ||
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | ILF2 NACA NOB1 ZNF185 SRPK2 VIRMA GTF3C3 ESF1 LMNB1 G3BP1 UPF2 CHD5 PES1 SMARCA4 EIF5B ACIN1 UTP20 SCRIB GOLGA2 | 4.29e-07 | 1257 | 135 | 19 | 36526897 |
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | CT47A1 KDM5C RTN4 RBM26 CDK11A AK9 MDN1 MICAL3 FKBP8 MAP4K4 GOLGA2 KDM1A | 6.00e-07 | 497 | 135 | 12 | 36774506 |
| Pubmed | SETD1B EP400 PPM1E GON4L VIRMA RUSC2 KANK1 ACIN1 MICAL3 SCRIB MAPKBP1 | 6.02e-07 | 407 | 135 | 11 | 12693553 | |
| Pubmed | Fibril treatment changes protein interactions of tau and α-synuclein in human neurons. | DMXL2 RANGAP1 ILF2 MAP1B RTN4 NEFM G3BP1 EIF5B SCRIB GNL1 KDM1A TBCD | 6.13e-07 | 498 | 135 | 12 | 36634849 |
| Pubmed | Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking. | RANGAP1 EP400 KDM5C SRCAP MDN1 GTF3C2 EHMT1 SMARCA4 ACIN1 NIPBL | 7.53e-07 | 332 | 135 | 10 | 32786267 |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | PHF12 KAT6A SRCAP GTF3C3 GTF3C2 CHD5 ATAD2B PES1 EHMT1 SMARCA4 TIMELESS NIPBL KDM1A | 7.83e-07 | 608 | 135 | 13 | 36089195 |
| Pubmed | ILF2 CENPB ZNF622 SARNP ESF1 MDN1 LMNB1 PES1 SMARCA4 UTP20 NIPBL | 8.01e-07 | 419 | 135 | 11 | 15635413 | |
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | CACNA1F RANGAP1 ILF2 ZNF316 ZNF622 SCAF1 MYO15B MDN1 LMNB1 ATAD2B GLIPR1L2 MAP3K9 UTP20 SCRIB | 1.15e-06 | 736 | 135 | 14 | 29676528 |
| Pubmed | 1.23e-06 | 21 | 135 | 4 | 16079250 | ||
| Pubmed | MKRN2 Physically Interacts with GLE1 to Regulate mRNA Export and Zebrafish Retinal Development. | 1.49e-06 | 358 | 135 | 10 | 32460013 | |
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | TMED1 RANGAP1 HDAC6 MAP1B RTN4 NACA ZNF185 SMYD5 LMNB1 G3BP1 CCDC47 SMARCA2 EIF5B PPME1 ACIN1 SCRIB GNL1 ENSA TBCD | 1.49e-06 | 1367 | 135 | 19 | 32687490 |
| Pubmed | TMED1 ILF2 EP400 SHFL NACA RBM26 SRPK2 VIRMA GTF3C3 SCAF1 LMNB1 G3BP1 UPF2 CCDC47 PES1 SMARCA4 ACIN1 GNL1 GOLGA2 | 1.56e-06 | 1371 | 135 | 19 | 36244648 | |
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | RANGAP1 ILF2 MAP1B ANP32B NACA RBM26 SRPK2 VTA1 SARNP GTF3C3 ESF1 NEFM MDN1 G3BP1 EIF5B MICAL3 ENSA | 2.45e-06 | 1149 | 135 | 17 | 35446349 |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | RANGAP1 ILF2 EP400 PHF12 SRCAP TERF1 SCAF1 MDN1 GTF3C2 LMNB1 POLR3E EHMT1 SMARCA4 ACIN1 UTP20 TAF5 NIPBL KDM1A | 2.86e-06 | 1294 | 135 | 18 | 30804502 |
| Pubmed | DMXL2 HDAC6 MAP1B KAT6A ZNF316 RBM26 KANK1 MDN1 CCDC47 ZNF335 SKOR2 TBCD DNAH11 | 3.10e-06 | 689 | 135 | 13 | 36543142 | |
| Pubmed | RANGAP1 SRPK2 GTF3C3 ESF1 GTF3C2 LMNB1 G3BP1 PES1 SMARCA4 EIF5B UTP20 | 3.16e-06 | 483 | 135 | 11 | 36912080 | |
| Pubmed | RANGAP1 MAP1B SRCAP SLC4A3 PRX ESF1 NEFM MDN1 LMNB1 CCDC47 CHD5 PES1 EIF5B ACIN1 CC2D2A IFT122 TNNT1 NIPBL PICK1 | 3.25e-06 | 1442 | 135 | 19 | 35575683 | |
| Pubmed | WDR76 Co-Localizes with Heterochromatin Related Proteins and Rapidly Responds to DNA Damage. | 3.48e-06 | 394 | 135 | 10 | 27248496 | |
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | ILF2 EP400 NACA NOB1 SCAF1 MDN1 LMNB1 UPF2 CCDC47 PES1 SMARCA2 SMARCA4 EIF5B PPME1 ACIN1 TAF5 NIPBL KDM1A | 3.69e-06 | 1318 | 135 | 18 | 30463901 |
| Pubmed | The ubiquitin-dependent ATPase p97 removes cytotoxic trapped PARP1 from chromatin. | 3.98e-06 | 400 | 135 | 10 | 35013556 | |
| Pubmed | LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling. | RANGAP1 POLE RTN4 APP GTF3C3 SLC4A2 LMNB1 UBE3A CCDC47 PES1 UTP20 TIMELESS SCRIB FKBP8 TBCD | 4.16e-06 | 942 | 135 | 15 | 31073040 |
| Pubmed | ILF2 CDK11A SRPK2 GTF3C3 GTF3C2 G3BP1 CCDC47 PES1 SMARCA4 EIF5B MAP4K4 GOLGA2 | 4.27e-06 | 601 | 135 | 12 | 33658012 | |
| Pubmed | CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality. | ILF2 ZNF622 SARNP VIRMA MDN1 LMNB1 G3BP1 CHD5 PES1 SMARCA2 SMARCA4 ACIN1 | 4.57e-06 | 605 | 135 | 12 | 28977666 |
| Pubmed | 4.64e-06 | 169 | 135 | 7 | 23665500 | ||
| Pubmed | PDE4D HDAC6 KDM5C RBM26 GTF3C2 EIF5B ACIN1 TIMELESS SCRIB NIPBL GOLGA2 | 4.64e-06 | 503 | 135 | 11 | 16964243 | |
| Pubmed | SARS-CoV-2 uses Spike glycoprotein to control the host's anaerobic metabolism by inhibiting LDHB. | ILF2 RTN4 NOB1 CDK11A SARNP VIRMA NEFM LMNB1 G3BP1 EIF5B ACIN1 TBCD | 4.72e-06 | 607 | 135 | 12 | 39147351 |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | RANGAP1 ILF2 EP400 MAP1B RBM26 CDK11A SARNP ESF1 LMNB1 G3BP1 ATAD2B SMARCA4 EIF5B ACIN1 NIPBL | 4.84e-06 | 954 | 135 | 15 | 36373674 |
| Pubmed | The cell proliferation antigen Ki-67 organises heterochromatin. | EP400 MAP1B SRPK2 G3BP1 PES1 SMARCA2 ACIN1 UTP20 SCRIB NIPBL | 4.94e-06 | 410 | 135 | 10 | 26949251 |
| Pubmed | Evolutionary history and genome organization of DUF1220 protein domains. | 6.73e-06 | 10 | 135 | 3 | 22973535 | |
| Pubmed | RANGAP1 ILF2 RTN4 ZNF622 SRPK2 APP ESF1 KANK1 LMNB1 G3BP1 SMARCA2 EIF5B ACIN1 CCDC9 GOLGA2 KDM1A TJP3 | 7.21e-06 | 1247 | 135 | 17 | 27684187 | |
| Pubmed | RANGAP1 EP400 PHF12 KDM5C RTN4 NACA GTF3C2 CHD5 EHMT1 MAP4K4 KDM1A | 7.46e-06 | 529 | 135 | 11 | 14621295 | |
| Pubmed | The PHLPP1 N-Terminal Extension Is a Mitotic Cdk1 Substrate and Controls an Interactome Switch. | 7.65e-06 | 256 | 135 | 8 | 33397691 | |
| Pubmed | RANGAP1 ILF2 GTF3C3 MDN1 LMNB1 G3BP1 PES1 SMARCA4 EIF5B SCRIB FKBP8 KDM1A | 7.80e-06 | 638 | 135 | 12 | 33239621 | |
| Pubmed | Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism. | 7.98e-06 | 341 | 135 | 9 | 32971831 | |
| Pubmed | C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains. | RANGAP1 ILF2 POLE NOB1 GTF3C3 MDN1 GTF3C2 LMNB1 G3BP1 UBE3A CCDC47 PES1 SMARCA4 SCRIB FKBP8 KDM1A TBCD | 8.00e-06 | 1257 | 135 | 17 | 37317656 |
| Pubmed | Interactome Rewiring Following Pharmacological Targeting of BET Bromodomains. | SARNP GTF3C3 MDN1 GTF3C2 PES1 SMARCA2 SMARCA4 EIF5B ACIN1 TAF5 NIPBL | 8.00e-06 | 533 | 135 | 11 | 30554943 |
| Pubmed | Interaction network of human early embryonic transcription factors. | 1.00e-05 | 351 | 135 | 9 | 38297188 | |
| Pubmed | A Chemical Proteomics Approach to Reveal Direct Protein-Protein Interactions in Living Cells. | 1.04e-05 | 35 | 135 | 4 | 29104064 | |
| Pubmed | DMXL2 HDAC6 KDM4C ZBTB47 SRPK2 APP TERF1 SLC4A3 NEFM UBE3A SMARCA4 PPME1 IFT122 SCRIB MAP4K4 NIPBL PICK1 | 1.06e-05 | 1285 | 135 | 17 | 35914814 | |
| Pubmed | Unbiased Identification of trans Regulators of ADAR and A-to-I RNA Editing. | 1.16e-05 | 271 | 135 | 8 | 32433965 | |
| Pubmed | 1.18e-05 | 453 | 135 | 10 | 29656893 | ||
| Pubmed | 1.18e-05 | 195 | 135 | 7 | 19454010 | ||
| Pubmed | 1.23e-05 | 12 | 135 | 3 | 10523658 | ||
| Pubmed | Mapping the NPHP-JBTS-MKS protein network reveals ciliopathy disease genes and pathways. | NPHP1 PDE4D RPGRIP1L EP400 MAP1B NACA NEFM EXOC6B CC2D2A IFT122 MAP4K4 | 1.35e-05 | 564 | 135 | 11 | 21565611 |
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | RANGAP1 PDE4D ILF2 ANP32B NACA ZNF622 VTA1 SARNP PTMS LMNB1 G3BP1 UBE3A PES1 EIF5B PPME1 TIMELESS GNL1 TBCD | 1.42e-05 | 1455 | 135 | 18 | 22863883 |
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 33077731 | ||
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 8670841 | ||
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 23163725 | ||
| Pubmed | Combined gene dosage requirement for SWI/SNF catalytic subunits during early mammalian development. | 1.50e-05 | 2 | 135 | 2 | 23076393 | |
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 15576411 | ||
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 15240517 | ||
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 26564006 | ||
| Pubmed | SMARCA4/SMARCA2-deficient Carcinoma of the Esophagus and Gastroesophageal Junction. | 1.50e-05 | 2 | 135 | 2 | 33027072 | |
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 23872584 | ||
| Pubmed | Alterations of the SWI/SNF chromatin remodelling subunit-BRG1 and BRM in hepatocellular carcinoma. | 1.50e-05 | 2 | 135 | 2 | 23088494 | |
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 20333683 | ||
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 34812766 | ||
| Pubmed | The E2 domains of APP and APLP1 share a conserved mode of dimerization. | 1.50e-05 | 2 | 135 | 2 | 21574595 | |
| Pubmed | Targeting of BRM Sensitizes BRG1-Mutant Lung Cancer Cell Lines to Radiotherapy. | 1.50e-05 | 2 | 135 | 2 | 30478150 | |
| Pubmed | The SWI/SNF ATPases Are Required for Triple Negative Breast Cancer Cell Proliferation. | 1.50e-05 | 2 | 135 | 2 | 25808524 | |
| Pubmed | Antagonistic roles for BRM and BRG1 SWI/SNF complexes in differentiation. | 1.50e-05 | 2 | 135 | 2 | 19144648 | |
| Pubmed | The catalytic subunit of the SWR1 remodeler is a histone chaperone for the H2A.Z-H2B dimer. | 1.50e-05 | 2 | 135 | 2 | 24507717 | |
| Pubmed | Light chain 1 of microtubule-associated protein 1B can negatively regulate the action of Pes1. | 1.50e-05 | 2 | 135 | 2 | 17308336 | |
| Pubmed | High expression of SMARCA4 or SMARCA2 is frequently associated with an opposite prognosis in cancer. | 1.50e-05 | 2 | 135 | 2 | 29391527 | |
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 37634210 | ||
| Interaction | NUP43 interactions | RANGAP1 SETD1B EP400 PHF12 KDM5C ZNF316 RBM26 GON4L SRCAP VIRMA SCAF1 LMNB1 ATAD2B EHMT1 SMARCA4 ACIN1 UTP20 TIMELESS NIPBL | 2.30e-08 | 625 | 131 | 19 | int:NUP43 |
| Interaction | ZNF330 interactions | POLE ZNF622 CDK11A SRPK2 SARNP VIRMA GTF3C3 ESF1 NBPF19 LMNB1 PES1 EHMT1 SMARCA4 UTP20 NIPBL PICK1 | 3.41e-08 | 446 | 131 | 16 | int:ZNF330 |
| Interaction | SIRT7 interactions | RANGAP1 ILF2 MAP1B POLE APP VIRMA GTF3C3 ESF1 NEFM MDN1 G3BP1 ATAD2B PES1 SMARCA2 SMARCA4 EIF5B ACIN1 UTP20 NIPBL KDM1A | 7.19e-08 | 744 | 131 | 20 | int:SIRT7 |
| Interaction | PARP1 interactions | RANGAP1 ZEB1 ILF2 HDAC6 EP400 CENPB ANP32B POLE CDK11A SRCAP VIRMA GTF3C3 ESF1 SCAF1 MDN1 GTF3C2 LMNB1 PES1 SMARCA2 EHMT1 SMARCA4 UTP20 TIMELESS SCRIB MAP4K4 NIPBL TBCD | 7.95e-08 | 1316 | 131 | 27 | int:PARP1 |
| Interaction | RNPS1 interactions | KAT6A CDK11A SRPK2 SARNP GTF3C3 ESF1 GTF3C2 LMNB1 UPF2 PES1 ACIN1 SCRIB TAF5 CCDC9 PICK1 | 1.17e-07 | 425 | 131 | 15 | int:RNPS1 |
| Interaction | PAX6 interactions | ZEB1 EP400 PHF12 RBM26 APP SRCAP GTF3C3 GTF3C2 UBE3A SMARCA2 EHMT1 SMARCA4 NIPBL PICK1 | 1.19e-07 | 366 | 131 | 14 | int:PAX6 |
| Interaction | CENPA interactions | CENPB POLE KAT6A VIRMA GTF3C3 ESF1 GTF3C2 LMNB1 CCDC47 PES1 SMARCA2 EHMT1 UTP20 NIPBL | 1.71e-07 | 377 | 131 | 14 | int:CENPA |
| Interaction | HNF4A interactions | EP400 ANP32B PHF12 SRCAP GTF3C3 GTF3C2 SMARCA2 EHMT1 SMARCA4 TAF5 NIPBL KDM1A | 2.46e-07 | 275 | 131 | 12 | int:HNF4A |
| Interaction | FOXK2 interactions | SETD1B MAP1B KAT6A RBM26 CDK11A SRPK2 ZNF428 VIRMA GTF3C3 DNAI2 EIF5B | 2.58e-07 | 225 | 131 | 11 | int:FOXK2 |
| Interaction | POLR3C interactions | 6.04e-07 | 110 | 131 | 8 | int:POLR3C | |
| Interaction | TOP1 interactions | ILF2 HDAC6 EP400 POLE KAT6A SRPK2 APP SRCAP VIRMA GTF3C3 SCAF1 GTF3C2 PES1 SMARCA4 ACIN1 UTP20 TNNT1 NIPBL | 6.07e-07 | 696 | 131 | 18 | int:TOP1 |
| Interaction | KAT5 interactions | RANGAP1 ZEB1 HDAC6 EP400 KAT6A APLP1 APP SRCAP TNNT1 RGL2 GOLGA2 PICK1 ZNF513 | 6.21e-07 | 358 | 131 | 13 | int:KAT5 |
| Interaction | BRD3 interactions | KDM4C SRPK2 APP SARNP VIRMA GTF3C3 SCAF1 GTF3C2 SMARCA2 EHMT1 SMARCA4 EIF5B ACIN1 TAF5 NIPBL | 7.91e-07 | 494 | 131 | 15 | int:BRD3 |
| Interaction | PBRM1 interactions | RANGAP1 HDAC6 EP400 KDM4C KDM5C KAT6A APP VIRMA UBE3A SMARCA2 SMARCA4 | 1.00e-06 | 258 | 131 | 11 | int:PBRM1 |
| Interaction | HECTD1 interactions | ILF2 RPGRIP1L CENPB MAP1B POLE KAT6A NACA ZNF622 SRPK2 SARNP TERF1 VIRMA GTF3C3 ESF1 MDN1 GTF3C2 G3BP1 UPF2 SMARCA4 ACIN1 UTP20 | 1.47e-06 | 984 | 131 | 21 | int:HECTD1 |
| Interaction | CIC interactions | RANGAP1 EP400 PHF12 POLE VIRMA GTF3C3 GTF3C2 LMNB1 POLR3E EHMT1 SMARCA4 ACIN1 SCRIB TAF5 GOLGA2 KDM1A PICK1 | 1.77e-06 | 673 | 131 | 17 | int:CIC |
| Interaction | LPP interactions | 1.80e-06 | 127 | 131 | 8 | int:LPP | |
| Interaction | MYCN interactions | ILF2 EP400 MAP1B NACA NOB1 CDK11A SRPK2 SARNP VIRMA GTF3C3 ESF1 NEFM SCAF1 GTF3C2 LMNB1 G3BP1 UPF2 PES1 SMARCA2 SMARCA4 EIF5B ACIN1 MAP4K4 CCDC9 KDM1A | 2.35e-06 | 1373 | 131 | 25 | int:MYCN |
| Interaction | NFIX interactions | ZEB1 EP400 PHF12 SRCAP GTF3C3 GTF3C2 SMARCA2 EHMT1 TAF5 NIPBL | 2.37e-06 | 227 | 131 | 10 | int:NFIX |
| Interaction | CSNK2B interactions | EP400 CENPB KDM5C KAT6A CDK11A APLP1 SARNP TERF1 ESF1 ATAD2B EHMT1 MICAL3 MAP4K4 GNL1 KDM1A TJP3 | 3.07e-06 | 625 | 131 | 16 | int:CSNK2B |
| Interaction | MCM7 interactions | ILF2 HDAC6 MAP1B VTA1 APP TERF1 VIRMA NEFM G3BP1 UBE3A TIMELESS GOLGA2 KDM1A | 3.12e-06 | 414 | 131 | 13 | int:MCM7 |
| Interaction | EP300 interactions | RANGAP1 ZEB1 ILF2 HDAC6 RTN4 KAT6A NACA NOB1 RBM26 SRPK2 SRCAP TERF1 VIRMA GTF3C3 PTMS GTF3C2 G3BP1 SMARCA2 SMARCA4 SCRIB FKBP8 GNL1 CCDC9 GOLGA2 KDM1A | 3.36e-06 | 1401 | 131 | 25 | int:EP300 |
| Interaction | PYHIN1 interactions | CENPB MAP1B NOB1 ZNF622 SRPK2 ZNF428 GTF3C3 SCAF1 MDN1 PES1 SMARCA4 EIF5B | 3.92e-06 | 358 | 131 | 12 | int:PYHIN1 |
| Interaction | SLX4 interactions | RANGAP1 EP400 CENPB NACA RBM26 CDK11A APP VIRMA GTF3C3 ESF1 MDN1 PES1 EHMT1 SMARCA4 NIPBL | 4.79e-06 | 572 | 131 | 15 | int:SLX4 |
| Interaction | WDCP interactions | 5.25e-06 | 104 | 131 | 7 | int:WDCP | |
| Interaction | H3C1 interactions | SETD1B HDAC6 KDM4C ANP32B KAT6A NACA SMYD5 SRCAP SARNP VIRMA GTF3C3 GTF3C2 PES1 SMARCA2 EHMT1 SMARCA4 TAF5 NIPBL KDM1A | 5.85e-06 | 901 | 131 | 19 | int:H3C1 |
| Interaction | OBSL1 interactions | RANGAP1 ILF2 EP400 RSPH6A APP SRCAP SCAF1 MDN1 LMNB1 G3BP1 PES1 SMARCA4 EIF5B ACIN1 UTP20 SCRIB MAP4K4 NIPBL KDM1A | 5.94e-06 | 902 | 131 | 19 | int:OBSL1 |
| Interaction | FBXL6 interactions | TMED1 RANGAP1 MAP1B NACA NOB1 RBM26 ZNF622 GON4L SRPK2 GTF3C3 ESF1 GTF3C2 CCDC47 PES1 FKBP8 | 6.02e-06 | 583 | 131 | 15 | int:FBXL6 |
| Interaction | KAT6A interactions | RANGAP1 CENPB KAT6A NOB1 ZNF622 SRPK2 TERF1 VIRMA ESF1 SCAF1 GTF3C2 CCDC47 SMARCA4 TAF5 | 6.04e-06 | 510 | 131 | 14 | int:KAT6A |
| Interaction | RPLP0 interactions | ZEB1 ILF2 RPGRIP1L HDAC6 KAT6A ZBTB47 SRPK2 APP SARNP VIRMA SCAF1 GTF3C2 G3BP1 UBE3A EIF5B GNL1 | 6.13e-06 | 660 | 131 | 16 | int:RPLP0 |
| Interaction | TOP3B interactions | RAPGEF6 SETD1B EP400 PHF12 POLE KAT6A NOB1 ZNF316 APP SRCAP NBPF1 SCAF1 MDN1 G3BP1 UPF2 ZNF335 CHD5 EHMT1 ACIN1 MICAL3 MAPKBP1 RGL2 PICK1 TBCD TJP3 | 7.81e-06 | 1470 | 131 | 25 | int:TOP3B |
| Interaction | TRIM28 interactions | RANGAP1 ILF2 HDAC6 MAP1B POLE KDM5C ZNF316 ZNF622 VTA1 SRCAP VIRMA LMNB1 UPF2 UBE3A CCDC47 PES1 SMARCA2 EHMT1 SMARCA4 PPME1 UTP20 TIMELESS SCRIB NIPBL KDM1A | 8.19e-06 | 1474 | 131 | 25 | int:TRIM28 |
| Interaction | MEN1 interactions | RANGAP1 ILF2 SETD1B EP400 RBM26 SRPK2 SRCAP GTF3C3 MDN1 GTF3C2 G3BP1 UPF2 UBE3A PES1 EHMT1 SMARCA4 EIF5B ACIN1 UTP20 GOLGA2 | 1.08e-05 | 1029 | 131 | 20 | int:MEN1 |
| Interaction | UBR4 interactions | RANGAP1 ZEB1 INSYN1 MAP1B SRPK2 APP VIRMA EIF5B GNL1 GOLGA2 KDM1A | 1.19e-05 | 334 | 131 | 11 | int:UBR4 |
| Interaction | DDX18 interactions | 1.19e-05 | 334 | 131 | 11 | int:DDX18 | |
| Interaction | NUMA1 interactions | RANGAP1 DCAF8L2 KAT6A R3HCC1 SRCAP TERF1 VIRMA ATAD2B SMARCA2 EHMT1 SMARCA4 EIF5B MAP4K4 | 1.19e-05 | 469 | 131 | 13 | int:NUMA1 |
| Interaction | THOC2 interactions | 1.35e-05 | 219 | 131 | 9 | int:THOC2 | |
| Interaction | CSNK2A1 interactions | RANGAP1 ZEB1 ANP32B KDM5C KAT6A NACA CDK11A ZNF428 APP GTF3C3 ESF1 POLR3E PES1 EHMT1 SMARCA4 EIF5B ACIN1 GNL1 KDM1A | 1.35e-05 | 956 | 131 | 19 | int:CSNK2A1 |
| Interaction | ETS1 interactions | 1.42e-05 | 121 | 131 | 7 | int:ETS1 | |
| Interaction | SIRT6 interactions | SETD1B EP400 SRPK2 SRCAP SARNP GTF3C3 ESF1 GTF3C2 G3BP1 UBE3A SMARCA2 EHMT1 SMARCA4 SCRIB KDM1A | 1.46e-05 | 628 | 131 | 15 | int:SIRT6 |
| Interaction | DRAP1 interactions | 1.46e-05 | 81 | 131 | 6 | int:DRAP1 | |
| Interaction | NBPF3 interactions | 1.47e-05 | 8 | 131 | 3 | int:NBPF3 | |
| Interaction | DDX23 interactions | MAP1B RBM26 CDK11A SRPK2 TERF1 VIRMA ESF1 NEFM SCAF1 LMNB1 PES1 ACIN1 UTP20 | 1.52e-05 | 480 | 131 | 13 | int:DDX23 |
| Interaction | CSNK2A2 interactions | HDAC6 EP400 KAT6A NACA CDK11A TERF1 VIRMA GTF3C3 G3BP1 POLR3E PES1 EHMT1 SMARCA4 GNL1 KDM1A PICK1 | 1.74e-05 | 718 | 131 | 16 | int:CSNK2A2 |
| Interaction | DDRGK1 interactions | TMED1 RANGAP1 ILF2 ROR2 NACA NOB1 RBM26 ZNF622 SRPK2 APP VIRMA GTF3C3 MDN1 GTF3C2 LMNB1 G3BP1 CCDC47 PES1 EIF5B UTP20 FKBP8 MAP4K4 | 1.75e-05 | 1249 | 131 | 22 | int:DDRGK1 |
| Interaction | NR3C1 interactions | HDAC6 CENPB PHF12 POLE RTN4 NOB1 VIRMA ESF1 PTMS NBPF15 MDN1 UBE3A CCDC47 SMARCA2 EHMT1 SMARCA4 NIPBL KDM1A DNAH11 | 1.75e-05 | 974 | 131 | 19 | int:NR3C1 |
| Interaction | POLR1G interactions | EP400 KAT6A CDK11A SRCAP GTF3C3 ESF1 MDN1 POLR3E PES1 EHMT1 SMARCA4 UTP20 NIPBL | 1.85e-05 | 489 | 131 | 13 | int:POLR1G |
| Interaction | NAA40 interactions | RANGAP1 RAPGEF6 EP400 MAP1B RTN4 NACA RBM26 ZNF622 SRCAP ESF1 G3BP1 PES1 SMARCA4 EIF5B PPME1 ACIN1 SCRIB NIPBL ENSA | 1.85e-05 | 978 | 131 | 19 | int:NAA40 |
| Interaction | CIT interactions | RANGAP1 ILF2 EP400 NACA CDK11A SARNP VIRMA ESF1 NEFM SCAF1 GTF3C2 LMNB1 G3BP1 PES1 SMARCA2 SMARCA4 EIF5B PPME1 ACIN1 UTP20 SCRIB TAF5 NIPBL KDM1A | 1.92e-05 | 1450 | 131 | 24 | int:CIT |
| Interaction | CPLANE1 interactions | 1.94e-05 | 25 | 131 | 4 | int:CPLANE1 | |
| Interaction | SMARCC2 interactions | KDM5C SRCAP TERF1 VIRMA GTF3C3 LMNB1 UPF2 UBE3A SMARCA2 SMARCA4 KDM1A | 1.99e-05 | 353 | 131 | 11 | int:SMARCC2 |
| Interaction | CBX3 interactions | ZEB1 EP400 KDM5C ZNF316 CDK11A VIRMA ESF1 PTMS CHD5 EHMT1 SMARCA4 EIF5B MAP4K4 NIPBL KDM1A | 2.02e-05 | 646 | 131 | 15 | int:CBX3 |
| Interaction | WWTR1 interactions | RANGAP1 ZEB1 RAPGEF6 EP400 MAP1B SRCAP NEFM GTF3C2 LMNB1 SMARCA4 SCRIB MAP4K4 | 2.04e-05 | 422 | 131 | 12 | int:WWTR1 |
| Interaction | H2BC1 interactions | 2.17e-05 | 178 | 131 | 8 | int:H2BC1 | |
| Interaction | APEX1 interactions | ZEB1 RAPGEF6 HDAC6 EP400 CCDC28B KDM4C KAT6A ZNF185 R3HCC1 CDK11A SRPK2 APP SRCAP TERF1 VIRMA SLC4A2 G3BP1 PES1 EHMT1 SMARCA4 NIPBL KDM1A | 2.28e-05 | 1271 | 131 | 22 | int:APEX1 |
| Interaction | POU5F1 interactions | ILF2 EP400 RTN4 NACA ZBTB47 GTF3C3 GTF3C2 CHD5 SMARCA2 SMARCA4 EIF5B ACIN1 KDM1A ZNF513 | 2.74e-05 | 584 | 131 | 14 | int:POU5F1 |
| Interaction | MECP2 interactions | DMXL2 RANGAP1 ILF2 HDAC6 EP400 MAP1B SRCAP SARNP TERF1 GTF3C3 ESF1 NEFM LMNB1 UPF2 PES1 SMARCA2 EHMT1 SMARCA4 EIF5B ACIN1 MAP4K4 NIPBL | 2.76e-05 | 1287 | 131 | 22 | int:MECP2 |
| Interaction | SUMO2 interactions | RANGAP1 EP400 ANP32B KDM5C NACA SRCAP PTMS MDN1 GTF3C2 EHMT1 SMARCA4 ACIN1 NIPBL KDM1A | 3.13e-05 | 591 | 131 | 14 | int:SUMO2 |
| Interaction | MCM4 interactions | 3.21e-05 | 306 | 131 | 10 | int:MCM4 | |
| Interaction | EPPK1 interactions | 3.34e-05 | 189 | 131 | 8 | int:EPPK1 | |
| Interaction | ZMYND11 interactions | 3.43e-05 | 94 | 131 | 6 | int:ZMYND11 | |
| Interaction | KDM5C interactions | 3.50e-05 | 139 | 131 | 7 | int:KDM5C | |
| Interaction | RPL31 interactions | ILF2 HDAC6 KAT6A NACA CDK11A SRPK2 APP VIRMA ESF1 SCAF1 G3BP1 CCDC47 PES1 ACIN1 UTP20 | 3.66e-05 | 680 | 131 | 15 | int:RPL31 |
| Interaction | TNIK interactions | INSYN1 ROR2 PPM1E VIRMA NEFM LMNB1 G3BP1 EHMT1 TAF5 MAP4K4 KDM1A | 3.99e-05 | 381 | 131 | 11 | int:TNIK |
| Interaction | ITPKB interactions | 4.10e-05 | 30 | 131 | 4 | int:ITPKB | |
| Interaction | SOX2 interactions | RANGAP1 ZEB1 PDE4D ILF2 KCNH8 EP400 MAP1B SHFL ANP32B RTN4 ZNF185 CDK11A SRPK2 MDN1 LMNB1 G3BP1 PES1 SMARCA2 EHMT1 SMARCA4 EIF5B NIPBL KDM1A | 4.21e-05 | 1422 | 131 | 23 | int:SOX2 |
| Interaction | BRCA2 interactions | HDAC6 POLE KDM5C PPM1E SRCAP TERF1 VIRMA ACIN1 TIMELESS NIPBL KDM1A | 4.29e-05 | 384 | 131 | 11 | int:BRCA2 |
| Interaction | FOXL1 interactions | 4.32e-05 | 196 | 131 | 8 | int:FOXL1 | |
| Interaction | S100A4 interactions | 4.38e-05 | 144 | 131 | 7 | int:S100A4 | |
| Interaction | RNF2 interactions | RANGAP1 EP400 CENPB KDM5C NOB1 CDK11A APP TERF1 VIRMA ESF1 G3BP1 UBE3A PES1 EHMT1 SMARCA4 ACIN1 KDM1A | 4.68e-05 | 866 | 131 | 17 | int:RNF2 |
| Interaction | GTF3C6 interactions | 4.68e-05 | 31 | 131 | 4 | int:GTF3C6 | |
| Interaction | SERBP1 interactions | RANGAP1 ZEB1 ILF2 HDAC6 MAP1B KDM5C KAT6A NACA RBM26 VTA1 APP VIRMA SCAF1 LMNB1 G3BP1 UPF2 UBE3A CCDC47 PES1 PPME1 FKBP8 PICK1 TBCD | 4.69e-05 | 1432 | 131 | 23 | int:SERBP1 |
| Interaction | BIRC3 interactions | DNHD1 RANGAP1 ILF2 DNAH10 ANP32B RTN4 NACA RBM26 GTF3C3 MDN1 GTF3C2 LMNB1 G3BP1 CCDC47 PES1 EHMT1 SMARCA4 EIF5B ACIN1 CC2D2A UTP20 KDM1A | 4.75e-05 | 1334 | 131 | 22 | int:BIRC3 |
| Interaction | FMR1 interactions | RANGAP1 ILF2 MAP1B KAT6A SRPK2 VIRMA G3BP1 SMARCA4 SCRIB MAP4K4 NIPBL KDM1A PICK1 | 4.79e-05 | 536 | 131 | 13 | int:FMR1 |
| Interaction | PES1 interactions | 4.88e-05 | 258 | 131 | 9 | int:PES1 | |
| Interaction | SRRM2 interactions | ILF2 HDAC6 MAP1B SRPK2 APP SARNP VIRMA LMNB1 PES1 SMARCA2 SMARCA4 ACIN1 | 4.93e-05 | 462 | 131 | 12 | int:SRRM2 |
| Interaction | SMARCA4 interactions | ZEB1 EP400 KDM4C KDM5C KAT6A SRCAP VIRMA GTF3C3 LMNB1 UPF2 SMARCA2 SMARCA4 | 4.93e-05 | 462 | 131 | 12 | int:SMARCA4 |
| Interaction | CHAF1A interactions | ANP32B KAT6A GTF3C3 ESF1 MDN1 SMARCA2 EHMT1 SMARCA4 TIMELESS KDM1A | 4.94e-05 | 322 | 131 | 10 | int:CHAF1A |
| Interaction | H2BC4 interactions | 5.03e-05 | 259 | 131 | 9 | int:H2BC4 | |
| Interaction | EEF1G interactions | RANGAP1 ILF2 HDAC6 MAP1B NACA VIRMA GTF3C3 SCAF1 CCDC47 ACIN1 TNNT1 RGL2 | 5.03e-05 | 463 | 131 | 12 | int:EEF1G |
| Interaction | GSK3A interactions | RAPGEF6 HDAC6 ROR2 SRPK2 VTA1 APP KANK1 MDN1 G3BP1 ACIN1 MICAL3 SCRIB | 5.14e-05 | 464 | 131 | 12 | int:GSK3A |
| Interaction | NECAB2 interactions | 5.14e-05 | 101 | 131 | 6 | int:NECAB2 | |
| Interaction | FBXO22 interactions | KDM4C CT47A1 KDM5C RTN4 RBM26 CDK11A AK9 MDN1 MICAL3 FKBP8 MAP4K4 GOLGA2 KDM1A | 5.16e-05 | 540 | 131 | 13 | int:FBXO22 |
| Interaction | BAIAP2 interactions | 5.17e-05 | 201 | 131 | 8 | int:BAIAP2 | |
| Interaction | NXF1 interactions | DNHD1 RANGAP1 RAPGEF6 RPGRIP1L HDAC6 MAP1B KDM4C KDM5C ROR2 R3HCC1 RBM26 SRPK2 SMYD5 SARNP ESF1 SLC4A2 KANK1 G3BP1 UPF2 PES1 SCRIB KDM1A | 5.36e-05 | 1345 | 131 | 22 | int:NXF1 |
| Interaction | PCBD1 interactions | 6.06e-05 | 104 | 131 | 6 | int:PCBD1 | |
| Interaction | RBM8A interactions | ILF2 KAT6A NACA NOB1 ZNF622 SRPK2 APP PTMS LMNB1 UPF2 ACIN1 CCDC9 | 6.18e-05 | 473 | 131 | 12 | int:RBM8A |
| Interaction | COIL interactions | PDE4D CDK11A SRPK2 APP GTF3C3 ESF1 MYO15B G3BP1 EHMT1 UTP20 NIPBL KDM1A PICK1 | 6.45e-05 | 552 | 131 | 13 | int:COIL |
| Interaction | SNCA interactions | DMXL2 RANGAP1 HDAC6 MAP1B RTN4 APLP1 APP VIRMA NEFM G3BP1 EIF5B SCRIB GNL1 ENSA TBCD | 6.56e-05 | 716 | 131 | 15 | int:SNCA |
| Interaction | ELF2 interactions | 7.28e-05 | 156 | 131 | 7 | int:ELF2 | |
| Interaction | SUPT5H interactions | RANGAP1 ILF2 EP400 TERF1 SCAF1 LMNB1 EIF5B ACIN1 NIPBL GOLGA2 KDM1A | 7.39e-05 | 408 | 131 | 11 | int:SUPT5H |
| Interaction | GTF3C3 interactions | 8.02e-05 | 214 | 131 | 8 | int:GTF3C3 | |
| Interaction | H3C3 interactions | PHF12 SRCAP GTF3C3 GTF3C2 CHD5 ATAD2B PES1 EHMT1 SMARCA4 TIMELESS NIPBL KDM1A | 9.51e-05 | 495 | 131 | 12 | int:H3C3 |
| Interaction | POLR1E interactions | CDK11A SRCAP GTF3C3 ESF1 MDN1 GTF3C2 POLR3E EHMT1 EIF5B UTP20 | 9.87e-05 | 350 | 131 | 10 | int:POLR1E |
| Interaction | H2BC8 interactions | ZEB1 EP400 GON4L SRCAP SARNP VIRMA ESF1 GTF3C2 CCDC47 EHMT1 SMARCA4 NIPBL KDM1A | 9.90e-05 | 576 | 131 | 13 | int:H2BC8 |
| Interaction | FTSJ3 interactions | ILF2 HDAC6 KAT6A NOB1 ZBTB47 ZNF622 SRPK2 VIRMA G3BP1 PES1 EIF5B | 9.96e-05 | 422 | 131 | 11 | int:FTSJ3 |
| Interaction | HDAC1 interactions | ZEB1 RAPGEF6 EP400 KDM4C PHF12 KDM5C PPM1E GON4L VTA1 VIRMA NEFM LMNB1 G3BP1 CCDC47 CHD5 SMARCA2 EHMT1 SMARCA4 KDM1A | 9.98e-05 | 1108 | 131 | 19 | int:HDAC1 |
| Interaction | MORF4L1 interactions | 1.00e-04 | 221 | 131 | 8 | int:MORF4L1 | |
| Interaction | KPNA1 interactions | HDAC6 EP400 ANP32B ESF1 LMNB1 G3BP1 SMARCA2 SMARCA4 UTP20 NIPBL | 1.01e-04 | 351 | 131 | 10 | int:KPNA1 |
| Interaction | VSIG1 interactions | 1.06e-04 | 72 | 131 | 5 | int:VSIG1 | |
| GeneFamily | Neuroblastoma breakpoint family | 3.59e-06 | 23 | 84 | 4 | 662 | |
| GeneFamily | Dyneins, axonemal | 6.28e-05 | 17 | 84 | 3 | 536 | |
| GeneFamily | PHD finger proteins|Lysine demethylases | 1.82e-04 | 24 | 84 | 3 | 485 | |
| GeneFamily | WD repeat domain containing | 2.17e-04 | 262 | 84 | 7 | 362 | |
| GeneFamily | PDZ domain containing | 7.12e-04 | 152 | 84 | 5 | 1220 | |
| GeneFamily | Adenylate kinases | 7.52e-04 | 9 | 84 | 2 | 356 | |
| GeneFamily | PHD finger proteins | 8.18e-04 | 90 | 84 | 4 | 88 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 1.55e-03 | 181 | 84 | 5 | 694 | |
| GeneFamily | GATA zinc finger domain containing|Myb/SANT domain containing | 1.92e-03 | 53 | 84 | 3 | 532 | |
| GeneFamily | General transcription factors|Xeroderma pigmentosum complementation groups|DNA helicases|ERCC excision repair associated | 5.97e-03 | 25 | 84 | 2 | 565 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | DMXL2 ZEB1 MAP1B KDM4C KAT6A SRPK2 APP TERF1 MDN1 GTF3C2 LMNB1 UPF2 UBE3A ATAD2B SMARCA2 UTP20 MICAL3 NIPBL | 3.92e-07 | 856 | 134 | 18 | M4500 |
| Coexpression | HOUNKPE_HOUSEKEEPING_GENES | TMED1 RANGAP1 ILF2 ANP32B PHF12 NACA NOB1 R3HCC1 SMYD5 SARNP GTF3C3 SCAF1 G3BP1 CCDC47 EIF5B FKBP8 ENSA KDM1A TBCD | 4.93e-06 | 1129 | 134 | 19 | M42508 |
| Coexpression | HOUNKPE_HOUSEKEEPING_GENES | TMED1 RANGAP1 ILF2 ANP32B PHF12 NACA NOB1 R3HCC1 SMYD5 SARNP GTF3C3 SCAF1 G3BP1 CCDC47 EIF5B FKBP8 ENSA KDM1A TBCD | 7.08e-06 | 1158 | 134 | 19 | MM1338 |
| Coexpression | GSE27786_NKCELL_VS_NKTCELL_DN | 8.83e-06 | 199 | 134 | 8 | M4852 | |
| Coexpression | GSE369_PRE_VS_POST_IL6_INJECTION_SOCS3_KO_LIVER_DN | 9.16e-06 | 200 | 134 | 8 | M5977 | |
| Coexpression | CAIRO_HEPATOBLASTOMA_CLASSES_UP | ILF2 GTF3C3 ESF1 MDN1 GTF3C2 POLR3E CCDC47 SMARCA4 EIF5B UTP20 TIMELESS SCRIB KDM1A | 1.62e-05 | 612 | 134 | 13 | M4772 |
| Coexpression | LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_DN | 2.23e-05 | 164 | 134 | 7 | M13108 | |
| Coexpression | BENPORATH_SOX2_TARGETS | ILF2 ANP32B KAT6A ZNF428 PPP1R15A APP SCAF1 KANK1 G3BP1 POLR3E ZNF335 ACIN1 ENSA TJP3 | 2.49e-05 | 734 | 134 | 14 | M3835 |
| Coexpression | FAN_OVARY_CL1_GPRC5A_TNFRS12A_HIGH_SELECTABLE_FOLLICLE_STROMAL_CELL | 2.70e-05 | 380 | 134 | 10 | M41703 | |
| Coexpression | TABULA_MURIS_SENIS_BRAIN_NON_MYELOID_NEURON_AGEING | INSYN1 R3HCC1 ZNF622 ZNF428 TERF1 SLC4A3 PTMS POLR3E ZNF335 CHD5 EXOC6B TAF5 RGL2 CCDC9 PICK1 TBCD | 3.06e-05 | 954 | 134 | 16 | MM3689 |
| Coexpression | ZHONG_PFC_C3_ASTROCYTE | ZNF316 CHGA SLC4A3 NEFM MDN1 CHD5 ATAD2B SMARCA2 MAP3K9 ZFTA | 3.29e-05 | 389 | 134 | 10 | M39102 |
| Coexpression | SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_UP | SOX12 POLE KDM5C RTN4 NACA G3BP1 SMARCA4 TAF5 GNL1 ENSA GOLGA2 | 4.06e-05 | 484 | 134 | 11 | M14665 |
| Coexpression | GSE3982_MAST_CELL_VS_TH1_DN | 7.38e-05 | 198 | 134 | 7 | M5454 | |
| Coexpression | GSE3982_MAST_CELL_VS_TH2_DN | 7.86e-05 | 200 | 134 | 7 | M5456 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.35e-07 | 194 | 134 | 8 | 4a2c127c90d1fefe604fcb9e796577d21b489dd6 | |
| ToppCell | Frontal_cortex-Neuronal|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 1.65e-07 | 199 | 134 | 8 | f88039d862f3bfa01dc39d2de4f3f548dc5a0e61 | |
| ToppCell | NS-moderate-d_07-13-Epithelial-Ciliated|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.55e-06 | 186 | 134 | 7 | 85787ff207f109ec7e3c0f729ba9bda739c2fdc9 | |
| ToppCell | PND10|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.79e-06 | 190 | 134 | 7 | d67e2814047c8df2ae4b7bc8be9539f5df6ecef2 | |
| ToppCell | Bronchial_Biopsy-Epithelial-Ciliated_1|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.99e-06 | 193 | 134 | 7 | 0b62a6ddd7c42efd9f39781971d1438501e1fa8d | |
| ToppCell | critical-Epithelial-Ciliated|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.35e-06 | 198 | 134 | 7 | ee2c8385c0bf4ea9f5c9517b52cf131af3fbdd40 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_|World / Primary Cells by Cluster | 2.43e-06 | 199 | 134 | 7 | 058373b4ac3cec2108cb24265628ff0a50646e33 | |
| ToppCell | NS-moderate-d_07-13-Epithelial-FOXN4+|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 8.15e-06 | 157 | 134 | 6 | 410c9d74a2085179cfb39853cb6d330fa98c9c1b | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.24e-05 | 169 | 134 | 6 | fba841664939c771881ba97f14ef1df6635c04ff | |
| ToppCell | ILEUM-non-inflamed-(3)_MNP-(3)_mature_DC|(3)_MNP / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.33e-05 | 171 | 134 | 6 | 341f9f79c1ed654ab347e25dc4936f89ffdf9617 | |
| ToppCell | facs-Spleen-nan-24m-Lymphocytic-nan|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.42e-05 | 173 | 134 | 6 | e07e126e9dac6f1160cb3191d2e8374f39155d0d | |
| ToppCell | Fetal_29-31_weeks-Epithelial-ciliated_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.66e-05 | 178 | 134 | 6 | de5d50d7ca9ee9eb62f50c88a0c6d47f0694b2e6 | |
| ToppCell | Striatum-Macroglia-POLYDENDROCYTE-P5|Striatum / BrainAtlas - Mouse McCarroll V32 | 1.95e-05 | 183 | 134 | 6 | f20b0d71f857ac35868fd80531050ad8b6091716 | |
| ToppCell | NS-moderate-d_16-33-Epithelial-Ciliated|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.07e-05 | 185 | 134 | 6 | 5e689c2fb36ce3ac2adc8d15f67107f21cf68868 | |
| ToppCell | Adult-Epithelial-ciliated_cell-D175|Adult / Lineage, Cell type, age group and donor | 2.07e-05 | 185 | 134 | 6 | 30f4980dee6cd5959655f8d74049f3bfb5312611 | |
| ToppCell | NS-critical-d_16-33-Epithelial-Ciliated|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.13e-05 | 186 | 134 | 6 | 76033438426d8f9c72cd6691a7baf92104c9f03d | |
| ToppCell | Epithelial-Epithelial-D_(Ciliated)|Epithelial / shred on cell class and cell subclass (v4) | 2.26e-05 | 188 | 134 | 6 | 8f30535a32968a81a304315a49c0d90a77d36948 | |
| ToppCell | Children_(3_yrs)-Epithelial-ciliated_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.26e-05 | 188 | 134 | 6 | 2b6dfc88be9ded7b88da9fe78a9cd9f9b3af8af3 | |
| ToppCell | Nasal_Brush-Epithelial-Ciliated_2|Nasal_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X | 2.40e-05 | 190 | 134 | 6 | 9ce7df056bfb24d70db4c3c4a2c57d89115de877 | |
| ToppCell | Nasal_Brush-Epithelial-Ciliated_2|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 2.40e-05 | 190 | 134 | 6 | 833481ace2800354712e2ce709d5cdfd0aed3d42 | |
| ToppCell | droplet-Pancreas-Endocrine-18m-Epithelial-pancreatic_A_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.40e-05 | 190 | 134 | 6 | db19c72d8c8053262b535068c5a9d4d696989cb1 | |
| ToppCell | Bronchial_Biopsy-Epithelial-Ciliated_1|Bronchial_Biopsy / Tissue, Lineage and Cell class of Lung Cells from 10X | 2.55e-05 | 192 | 134 | 6 | be592e661367affced9ebe80849b466e6adb3a34 | |
| ToppCell | H1299-infected|H1299 / Cell line, Condition and Strain | 2.55e-05 | 192 | 134 | 6 | 9cf8049bdc3e0f81ce69042beac72b08d8f38b4e | |
| ToppCell | 343B-Lymphocytic-ILC-ILC-1|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 2.55e-05 | 192 | 134 | 6 | 445985fe1bcd33e4f0a1704b27988fbfc9334538 | |
| ToppCell | Posterior_cortex-Neuronal|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 2.62e-05 | 193 | 134 | 6 | b4989e3436e84dbec3789b46057e0f7a0ebf09d4 | |
| ToppCell | facs-Skin-Telogen-3m-Epithelial|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.70e-05 | 194 | 134 | 6 | 4d7fc4d0a55abb3b645116d13a983bbedc55f70c | |
| ToppCell | NS-critical-d_07-13-Epithelial-Ciliated|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.70e-05 | 194 | 134 | 6 | 1ae8a10e508e672e6677f0e3c986ac30d05adeb3 | |
| ToppCell | facs-Skin-Telogen-3m|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.70e-05 | 194 | 134 | 6 | ba10fc5929649bb994c3f1d2ce6ca3167fa9b11b | |
| ToppCell | facs-Skin-Telogen|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.70e-05 | 194 | 134 | 6 | bafecab8d48fc94ffd93f0d054b5f32c04b6b3f6 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.78e-05 | 195 | 134 | 6 | 0e763f36786515698b593e5c93f6a56619c1242d | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.78e-05 | 195 | 134 | 6 | 581b04220587e1d5198b1abd6965965ace7803e7 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.78e-05 | 195 | 134 | 6 | 93b1559382a12cfb158aa5fac7386e38b4f87989 | |
| ToppCell | moderate-Epithelial-Ciliated|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.78e-05 | 195 | 134 | 6 | 3486eae5fdb062a75a907b896c9d7b396d2aa195 | |
| ToppCell | moderate-Epithelial-Ciliated|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.78e-05 | 195 | 134 | 6 | e80f5cdf0b18066b3e6c2f5452e58f101c67932c | |
| ToppCell | BL-critical-LOC-Epithelial-Ciliated|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.78e-05 | 195 | 134 | 6 | 07a6bcef6af93ed87df455dee624037cb75e011a | |
| ToppCell | critical-Epithelial-Ciliated|critical / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.86e-05 | 196 | 134 | 6 | 27b855c6e1ae44f16db998cf0e81bd686b9cee7e | |
| ToppCell | NS-control-d_0-4-Epithelial-Ciliated|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.86e-05 | 196 | 134 | 6 | d46ab80554dd3c1cc81e1938ea2acfd5e85c6d2a | |
| ToppCell | PSB-critical-LOC-Epithelial-Ciliated|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.94e-05 | 197 | 134 | 6 | 6865f4831eb23794fb88a8649d48d497bbae3f44 | |
| ToppCell | control-Epithelial-Ciliated|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.94e-05 | 197 | 134 | 6 | e453d085182364ca347cbcc9dc995c62c3353016 | |
| ToppCell | control-Epithelial-Ciliated|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.94e-05 | 197 | 134 | 6 | d4e963c1f82996371bf3d63578ee9fce8e00c5a8 | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_ciliated-Deuterosomal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.03e-05 | 198 | 134 | 6 | f31790442ef142f1c0c49bf3daf2d0efb193d2c9 | |
| ToppCell | LPS_only-Epithelial_airway-airway_epithelial-Ciliated|LPS_only / Treatment groups by lineage, cell group, cell type | 3.03e-05 | 198 | 134 | 6 | 6d90b541fde357fbb40f8f7d4e8628a48b679718 | |
| ToppCell | Neuron|World / Primary Cells by Cluster | 3.11e-05 | 199 | 134 | 6 | 1f8104fd92f04690b41d9d07ac08dc59d76bb97d | |
| ToppCell | Neuron-Postmitotic|World / Primary Cells by Cluster | 3.11e-05 | 199 | 134 | 6 | 1973527f8a7d4c6490d75c0d0ea153688166a08b | |
| ToppCell | Bronchus_Control_(B.)-Epithelial-TX-Ciliated|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 3.20e-05 | 200 | 134 | 6 | 6a2ccc71a0cbe04a542c379b28b5006de53981c3 | |
| ToppCell | TCGA-Bile_Duct-Primary_Tumor-Cholangiocarcinoma|TCGA-Bile_Duct / Sample_Type by Project: Shred V9 | 3.20e-05 | 200 | 134 | 6 | ad2a6da0b1ae7a9212a3c91e5eec4baa7481d8dc | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-2m-Neuronal|2m / Sample Type, Dataset, Time_group, and Cell type. | 3.20e-05 | 200 | 134 | 6 | 60b86c4a4e247b2673d31b085b440a6e574393bb | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial-Activated_Alv_Cap|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 3.20e-05 | 200 | 134 | 6 | 89821a264e872ed53e08e9d3609d5cc5c314503e | |
| ToppCell | Biopsy_IPF-Epithelial-Ciliated|Biopsy_IPF / Sample group, Lineage and Cell type | 3.20e-05 | 200 | 134 | 6 | bb8c99156e547a8eb6599b6b6bc3c66bf77af7f8 | |
| ToppCell | Control_saline-Endothelial-Endothelial|Control_saline / Treatment groups by lineage, cell group, cell type | 3.20e-05 | 200 | 134 | 6 | e77eba6172cabf85b8028638ed35299f2f079cd8 | |
| ToppCell | (09)_Interm._secr.>cil.|World / shred by cell type by condition | 3.20e-05 | 200 | 134 | 6 | 3305e14dba12e94da42f0414fdc7a2c8caf0a183 | |
| ToppCell | TCGA-Bile_Duct-Primary_Tumor|TCGA-Bile_Duct / Sample_Type by Project: Shred V9 | 3.20e-05 | 200 | 134 | 6 | 0350e5ffd36033099b7e32a1fdd790fff99790dc | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW26-Neuronal-Cortical_neuron|GW26 / Sample Type, Dataset, Time_group, and Cell type. | 3.20e-05 | 200 | 134 | 6 | 5b3df61ff421846ef4cabf1bd5355534c8b95509 | |
| ToppCell | Control_saline-Endothelial|Control_saline / Treatment groups by lineage, cell group, cell type | 3.20e-05 | 200 | 134 | 6 | 3372c488a39fe812fa94e4f0564594186fea3db5 | |
| ToppCell | 5'-GW_trimst-1|5' / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.20e-05 | 200 | 134 | 6 | a4c6d0cccba7aee35eaedf29faff32b9494b6582 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Upper_Layer_Occipital|World / Primary Cells by Cluster | 3.20e-05 | 200 | 134 | 6 | 6bbe8e1f3e91678f1bfb14945365c1578a59a604 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Upper_Layer_Occipital-19|World / Primary Cells by Cluster | 3.20e-05 | 200 | 134 | 6 | c831d9e0a7178e3634da45548f91fa9e8dc6557c | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Epithelial-Ciliated_2|Transplant_Alveoli_and_parenchyma / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.42e-04 | 165 | 134 | 5 | 731147b4337fd0de4383dc8170b4f9ccd98caec6 | |
| ToppCell | facs-Trachea-nan-24m-Mesenchymal-smooth_muscle_cell_of_trachea|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.55e-04 | 168 | 134 | 5 | 6c7b490b6c844d0ea4c07edfc24c02284f9533c4 | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Lymphocytic-B_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.03e-04 | 178 | 134 | 5 | d3cbdec9d75f076e565baca05ede292cca7758a4 | |
| ToppCell | facs-Heart-RA-18m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.03e-04 | 178 | 134 | 5 | b505e2550860e777535ee95f29c936242fd607f1 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Multiciliated_(nasal)-Multiciliated_(nasal)_L.0.3.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.13e-04 | 180 | 134 | 5 | 1f1af4474f3f0ac3c0d6b1a6c875c354d36d8eec | |
| ToppCell | Fetal_29-31_weeks-Epithelial-ciliated_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.19e-04 | 181 | 134 | 5 | dfce05bd472f67e6e2bb60ebd6fd34f0a9aeeca6 | |
| ToppCell | wk_15-18-Epithelial-Proximal_epithelial-Deuterosomal|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 2.25e-04 | 182 | 134 | 5 | 000eca5baa6eb2335a1e6d76a13fff5382b0e150 | |
| ToppCell | 367C-Epithelial_cells-Epithelial-F_(Ciliated)-|367C / Donor, Lineage, Cell class and subclass (all cells) | 2.30e-04 | 183 | 134 | 5 | b1336eac5adbffade4cef3e0ce3de75a781ae365 | |
| ToppCell | 367C-Epithelial_cells-Epithelial-F_(Ciliated)|367C / Donor, Lineage, Cell class and subclass (all cells) | 2.30e-04 | 183 | 134 | 5 | cc57dcb59c68d68a546dc108dd9e009b2aab8da5 | |
| ToppCell | Children_(3_yrs)-Epithelial-ciliated_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.36e-04 | 184 | 134 | 5 | 5daff849625f2f41d56615569c0ed59cd733b34c | |
| ToppCell | 5'-GW_trimst-1-SmallIntestine-Neuronal-neurons_B-Branch_B1_(eMN)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.42e-04 | 185 | 134 | 5 | ef996f4cdbc3971c6c0460d13df64b075ab22154 | |
| ToppCell | 5'-GW_trimst-1-SmallIntestine-Neuronal-neurons_B|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.42e-04 | 185 | 134 | 5 | d51342a3979bd728a80e04126059a3fd8a0dbe3b | |
| ToppCell | COPD-Lymphoid-B|COPD / Disease state, Lineage and Cell class | 2.42e-04 | 185 | 134 | 5 | 925e79c35c381dd44ec5fb921dca09ce43140135 | |
| ToppCell | COVID-19-Epithelial_cells-Airway_ciliated|COVID-19 / group, cell type (main and fine annotations) | 2.42e-04 | 185 | 134 | 5 | 18a40f0a338aa398d81384b5159fb80ce8a2020c | |
| ToppCell | P28-Epithelial-airway_epithelial_cell-club_cell|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.48e-04 | 186 | 134 | 5 | a26811481668fa25c48a064a56c198685693ad8d | |
| ToppCell | P28-Epithelial-airway_epithelial_cell|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.48e-04 | 186 | 134 | 5 | df80f101954b8ec6ccdb03e702de22e70b65181f | |
| ToppCell | facs-Lung-EPCAM-3m-Epithelial-Ciliated_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.54e-04 | 187 | 134 | 5 | 04dba2ed09ee4180830bdf0191921696697ea234 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-ciliated_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.54e-04 | 187 | 134 | 5 | 9e10ed56090d82589bc457788282f664b70ace4b | |
| ToppCell | 21-Trachea-Epithelial-Intermediate_ciliated|Trachea / Age, Tissue, Lineage and Cell class | 2.54e-04 | 187 | 134 | 5 | 1a2178a195d078d1963947b327c6d0d4f2f48341 | |
| ToppCell | facs-Lung-EPCAM-3m-Epithelial-ciliated_columnar_cell_of_tracheobronchial_tree|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.54e-04 | 187 | 134 | 5 | 805dafe22f835ece4dd091d8030d0a63b52a48dd | |
| ToppCell | tumor_Lung-Epithelial_cells-tS3|tumor_Lung / Location, Cell class and cell subclass | 2.61e-04 | 188 | 134 | 5 | 26326b4e298e33f9ba393fc632238aa8c54b1ea3 | |
| ToppCell | Epithelial-ciliated_cell|World / Lineage, Cell type, age group and donor | 2.61e-04 | 188 | 134 | 5 | 61a459f3fe57e5728efc72637ff2edc2d343492b | |
| ToppCell | facs-Pancreas-Endocrine-24m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.61e-04 | 188 | 134 | 5 | a91443aa8fa8fa87f7501c59219daa0305bd0bbf | |
| ToppCell | droplet-Pancreas-Endocrine-18m-Epithelial-pancreatic_A_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.67e-04 | 189 | 134 | 5 | ce3fbaf9642785c8adf6edaeae20998bca558928 | |
| ToppCell | cellseq2-Endothelial-Endothelial_Vascular-Endothelial_large_blood_vessel-VEC|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.67e-04 | 189 | 134 | 5 | bccb3481ffed597c845fe860da658505316105b5 | |
| ToppCell | Epithelial-D_(Ciliated)|World / shred on cell class and cell subclass (v4) | 2.67e-04 | 189 | 134 | 5 | 0bf560b595c7a8450a46bc821b742b67965bd9f9 | |
| ToppCell | PND01-Epithelial-Epithelial_Airway|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.67e-04 | 189 | 134 | 5 | 38cde34295566a4ecaf7d0a81c5a192cf17d0459 | |
| ToppCell | Multiciliated|World / shred by cell class for nasal brushing | 2.67e-04 | 189 | 134 | 5 | 34b110aef839376228c5a403a6b5047a945f472b | |
| ToppCell | COPD-Epithelial-Ciliated|Epithelial / Disease state, Lineage and Cell class | 2.67e-04 | 189 | 134 | 5 | 3e77883db34722b9ce0a03ea74caefc92dc7feff | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.74e-04 | 190 | 134 | 5 | 91ba66d4b56c59523485b17738e93f14bb00afa4 | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Stem-like-OPC-like-OPC-like-A|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.74e-04 | 190 | 134 | 5 | a28e14fff75c36b1a8634eaf3f305e3206fdc2ed | |
| ToppCell | P07|World / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.74e-04 | 190 | 134 | 5 | 38a613a9bca0ba040c3ada00286d1ce6f83ab23a | |
| ToppCell | Myeloid-Myeloid-B_(Activated_Macrophage)|Myeloid / shred on cell class and cell subclass (v4) | 2.81e-04 | 191 | 134 | 5 | 7bf125249af1e8bb138ed4d999fdd74b03ab2447 | |
| ToppCell | E18.5-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Deuterosomal-Deuterosomal_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.81e-04 | 191 | 134 | 5 | e8d56e9f43943e9cc4dce83f2c234f19c2dd487d | |
| ToppCell | E18.5-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Deuterosomal|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.81e-04 | 191 | 134 | 5 | 52e8d7dfaf1ebb6df8bf3a1f4546af59faa67657 | |
| ToppCell | facs-Pancreas-Endocrine-24m-Epithelial|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.81e-04 | 191 | 134 | 5 | a251b134f67a0a1ef3a42f50042f128a17f20b22 | |
| ToppCell | PND01-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.81e-04 | 191 | 134 | 5 | 96483adb97c81208aa513782550acd8a08b63866 | |
| ToppCell | (11)_FOXN4+-(0)_Reference|(11)_FOXN4+ / shred by cell type by condition | 2.87e-04 | 192 | 134 | 5 | ef06f96b934dd05b40025f8215b6d919d3a17045 | |
| ToppCell | Ciliated-cil-3|World / Class top | 2.87e-04 | 192 | 134 | 5 | 4989ebb8812b8af1870599acd932849122c05a29 | |
| ToppCell | multiciliated|World / shred by cell class for turbinate | 2.87e-04 | 192 | 134 | 5 | 0f89ea0deb651ca11531c51ee94e0233608d22ea | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.87e-04 | 192 | 134 | 5 | 1b6cac8156e608061e1405e36e18d185b6fa8f6f | |
| ToppCell | IPF-Epithelial-Ciliated|IPF / Disease state, Lineage and Cell class | 2.87e-04 | 192 | 134 | 5 | 354adc1354bf596fbc60dd45c0169688e6f45165 | |
| ToppCell | ASK452-Epithelial-Ciliated|Epithelial / Donor, Lineage and Cell class of Lung cells from Dropseq | 2.94e-04 | 193 | 134 | 5 | c0d10075862ac878aa05fc49c8b73e470783bf16 | |
| Drug | Acacetin [480-44-4]; Down 200; 14uM; PC3; HT_HG-U133A | 2.25e-06 | 195 | 133 | 9 | 4324_DN | |
| Drug | Ranitidine hydrochloride [66357-59-3]; Down 200; 11.4uM; PC3; HT_HG-U133A | 2.66e-06 | 199 | 133 | 9 | 6324_DN | |
| Drug | 17-AAG; Up 200; 1uM; MCF7; HT_HG-U133A | 1.70e-05 | 191 | 133 | 8 | 5953_UP | |
| Drug | Flupentixol dihydrochloride cis-(Z) [2413-38-9]; Down 200; 7.8uM; MCF7; HT_HG-U133A | 1.97e-05 | 195 | 133 | 8 | 5307_DN | |
| Drug | Pramoxine hydrochloride [637-58-1]; Down 200; 12.2uM; MCF7; HT_HG-U133A | 1.97e-05 | 195 | 133 | 8 | 4368_DN | |
| Drug | colchicine; Down 200; 1uM; SKMEL5; HG-U133A | 1.97e-05 | 195 | 133 | 8 | 630_DN | |
| Drug | Chicago sky blue 6B [2610-05-1]; Down 200; 4uM; MCF7; HT_HG-U133A | 2.20e-05 | 198 | 133 | 8 | 4971_DN | |
| Drug | Etoposide [33419-42-0]; Down 200; 6.8uM; PC3; HT_HG-U133A | 2.20e-05 | 198 | 133 | 8 | 6681_DN | |
| Drug | Atracurium besylate [64228-81-5]; Down 200; 3.2uM; PC3; HT_HG-U133A | 2.20e-05 | 198 | 133 | 8 | 1824_DN | |
| Drug | Phenylpropanolamine hydrochloride [154-41-6]; Down 200; 21.4uM; MCF7; HT_HG-U133A | 2.20e-05 | 198 | 133 | 8 | 5298_DN | |
| Drug | estradiol, USP; Up 200; 0.01uM; HL60; HG-U133A | 2.20e-05 | 198 | 133 | 8 | 782_UP | |
| Drug | Atracurium besylate [64228-81-5]; Down 200; 3.2uM; MCF7; HT_HG-U133A | 2.28e-05 | 199 | 133 | 8 | 1702_DN | |
| Drug | Exiproben | 4.13e-05 | 12 | 133 | 3 | CID000018995 | |
| Drug | 17-AAG; Up 200; 1uM; MCF7; HT_HG-U133A | 7.48e-05 | 174 | 133 | 7 | 5215_UP | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 7.48e-05 | 174 | 133 | 7 | 3993_DN | |
| Drug | Strophantine octahydrate [11018-89-6]; Up 200; 5.4uM; HL60; HT_HG-U133A | 7.48e-05 | 174 | 133 | 7 | 1302_UP | |
| Drug | 17-AAG; Up 200; 1uM; MCF7; HT_HG-U133A_EA | 7.75e-05 | 175 | 133 | 7 | 1006_UP | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 8.33e-05 | 177 | 133 | 7 | 6340_DN | |
| Drug | Dihydroergotamine tartrate [5989-77-5]; Down 200; 3uM; HL60; HG-U133A | 8.93e-05 | 179 | 133 | 7 | 1398_DN | |
| Drug | 17-DMAG; Up 200; 0.1uM; MCF7; HT_HG-U133A_EA | 1.06e-04 | 184 | 133 | 7 | 1051_UP | |
| Drug | 17-AAG; Up 200; 1uM; MCF7; HT_HG-U133A | 1.13e-04 | 186 | 133 | 7 | 5585_UP | |
| Drug | radicicol, diheterospora chlamydosporia; Up 200; 0.1uM; MCF7; HT_HG-U133A | 1.30e-04 | 190 | 133 | 7 | 5579_UP | |
| Drug | 2-propylpentanoic acid; Down 200; 1000uM; SKMEL5; HG-U133A | 1.43e-04 | 193 | 133 | 7 | 629_DN | |
| Drug | Albendazole [54965-21-8]; Down 200; 15uM; HL60; HG-U133A | 1.47e-04 | 194 | 133 | 7 | 1547_DN | |
| Drug | Levonordefrin [829-74-3]; Down 200; 21.8uM; PC3; HT_HG-U133A | 1.47e-04 | 194 | 133 | 7 | 5854_DN | |
| Drug | Oxymetazoline hydrochloride [2315-02-8]; Up 200; 13.4uM; PC3; HT_HG-U133A | 1.47e-04 | 194 | 133 | 7 | 2114_UP | |
| Drug | Ofloxacin [82419-36-1]; Up 200; 11uM; PC3; HT_HG-U133A | 1.52e-04 | 195 | 133 | 7 | 7372_UP | |
| Drug | Tocopherol (R,S) [10191-41-0]; Up 200; 9.2uM; MCF7; HT_HG-U133A | 1.57e-04 | 196 | 133 | 7 | 3256_UP | |
| Drug | Orphenadrine hydrochloride [341-69-5]; Down 200; 13uM; MCF7; HT_HG-U133A | 1.57e-04 | 196 | 133 | 7 | 4359_DN | |
| Drug | Pilocarpine nitrate [148-72-1]; Down 200; 14.8uM; MCF7; HT_HG-U133A | 1.62e-04 | 197 | 133 | 7 | 5341_DN | |
| Drug | R(+)-verapamil hydrochloride; Down 200; 10uM; MCF7; HG-U133A | 1.62e-04 | 197 | 133 | 7 | 164_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; HL60; HT_HG-U133A | 1.62e-04 | 197 | 133 | 7 | 6143_DN | |
| Drug | Altretamine [654-05-6]; Down 200; 19uM; HL60; HT_HG-U133A | 1.62e-04 | 197 | 133 | 7 | 3090_DN | |
| Drug | Diazoxide [364-98-7]; Down 200; 17.4uM; PC3; HT_HG-U133A | 1.62e-04 | 197 | 133 | 7 | 5810_DN | |
| Drug | Etomidate [33125-97-2]; Down 200; 16.4uM; HL60; HT_HG-U133A | 1.62e-04 | 197 | 133 | 7 | 2958_DN | |
| Drug | Clopamide [636-54-4]; Down 200; 11.6uM; MCF7; HT_HG-U133A | 1.62e-04 | 197 | 133 | 7 | 5402_DN | |
| Drug | Hydroflumethiazide [135-09-1]; Up 200; 12uM; PC3; HT_HG-U133A | 1.62e-04 | 197 | 133 | 7 | 7259_UP | |
| Drug | rapamycin; Down 200; 0.1uM; HL60; HG-U133A | 1.62e-04 | 197 | 133 | 7 | 362_DN | |
| Drug | Furaltadone hydrochloride [3759-92-0]; Down 200; 11uM; HL60; HT_HG-U133A | 1.62e-04 | 197 | 133 | 7 | 2554_DN | |
| Drug | trifluoperazine dihydrochloride; Down 200; 10uM; MCF7; HT_HG-U133A | 1.62e-04 | 197 | 133 | 7 | 6984_DN | |
| Drug | Diprophylline [479-18-5]; Down 200; 15.8uM; MCF7; HT_HG-U133A | 1.62e-04 | 197 | 133 | 7 | 5482_DN | |
| Drug | haloperidol; Down 200; 10uM; MCF7; HT_HG-U133A | 1.67e-04 | 198 | 133 | 7 | 1669_DN | |
| Drug | Trifluoperazine dihydrochloride [440-17-5]; Down 200; 8.4uM; PC3; HT_HG-U133A | 1.67e-04 | 198 | 133 | 7 | 6341_DN | |
| Drug | troglitazone; Down 200; 10uM; MCF7; HT_HG-U133A | 1.67e-04 | 198 | 133 | 7 | 6991_DN | |
| Drug | cis-4,7,10,13,16,19-Docosahexaenoic acid ethyl ester; Up 200; 100uM; PC3; HG-U133A | 1.67e-04 | 198 | 133 | 7 | 664_UP | |
| Drug | Levopropoxyphene napsylate [5714-90-9]; Up 200; 7.4uM; HL60; HT_HG-U133A | 1.67e-04 | 198 | 133 | 7 | 2980_UP | |
| Drug | Sulfisoxazole [127-69-5]; Down 200; 15uM; HL60; HG-U133A | 1.67e-04 | 198 | 133 | 7 | 1603_DN | |
| Drug | Oxytetracycline dihydrate [6153-64-6]; Down 200; 8uM; HL60; HG-U133A | 1.67e-04 | 198 | 133 | 7 | 1553_DN | |
| Drug | Sulconazole nitrate [61318-91-0]; Down 200; 8.6uM; PC3; HT_HG-U133A | 1.72e-04 | 199 | 133 | 7 | 6652_DN | |
| Drug | Cefixime [79350-37-1]; Down 200; 8.8uM; MCF7; HT_HG-U133A | 1.72e-04 | 199 | 133 | 7 | 4390_DN | |
| Drug | Azlocillin sodium salt [37091-65-9]; Down 200; 8.2uM; PC3; HT_HG-U133A | 1.72e-04 | 199 | 133 | 7 | 5788_DN | |
| Drug | 2-Aminobenzenesulfonamide [3306-62-5]; Down 200; 23.2uM; PC3; HT_HG-U133A | 1.72e-04 | 199 | 133 | 7 | 6321_DN | |
| Drug | Theophylline monohydrate [5967-84-0]; Down 200; 20.2uM; PC3; HT_HG-U133A | 1.72e-04 | 199 | 133 | 7 | 4228_DN | |
| Drug | Letrozole [112809-51-5]; Down 200; 14uM; MCF7; HT_HG-U133A | 1.78e-04 | 200 | 133 | 7 | 7336_DN | |
| Drug | Ricinine [524-40-3]; Down 200; 24.4uM; MCF7; HT_HG-U133A | 1.78e-04 | 200 | 133 | 7 | 6206_DN | |
| Drug | Rilmenidine hemifumarate [54187-04-1]; Down 200; 8.4uM; MCF7; HT_HG-U133A | 1.78e-04 | 200 | 133 | 7 | 6512_DN | |
| Disease | Primary Ciliary Dyskinesia | 4.75e-05 | 47 | 125 | 4 | C4551720 | |
| Disease | COACH syndrome | 5.33e-05 | 3 | 125 | 2 | cv:C1857662 | |
| Disease | JOUBERT SYNDROME 4 (disorder) | 5.33e-05 | 3 | 125 | 2 | C1846790 | |
| Disease | Ciliary Motility Disorders | 5.33e-05 | 3 | 125 | 2 | C0008780 | |
| Disease | Familial aplasia of the vermis | 8.03e-05 | 20 | 125 | 3 | cv:C0431399 | |
| Disease | COACH syndrome | 1.06e-04 | 4 | 125 | 2 | C1857662 | |
| Disease | Ciliopathies | 1.08e-04 | 110 | 125 | 5 | C4277690 | |
| Disease | MENTAL RETARDATION, AUTOSOMAL DOMINANT 12 | 1.77e-04 | 5 | 125 | 2 | C3281201 | |
| Disease | Global developmental delay | 2.62e-04 | 133 | 125 | 5 | C0557874 | |
| Disease | nephronophthisis (is_implicated_in) | 2.64e-04 | 6 | 125 | 2 | DOID:12712 (is_implicated_in) | |
| Disease | Melanoma, Cloudman S91 | 3.69e-04 | 7 | 125 | 2 | C0009075 | |
| Disease | Melanoma, B16 | 3.69e-04 | 7 | 125 | 2 | C0004565 | |
| Disease | Nephronophthisis, familial juvenile | 3.69e-04 | 7 | 125 | 2 | C1855681 | |
| Disease | Melanoma, Experimental | 3.69e-04 | 7 | 125 | 2 | C0025205 | |
| Disease | Alzheimer's disease 1 (implicated_via_orthology) | 3.69e-04 | 7 | 125 | 2 | DOID:0080348 (implicated_via_orthology) | |
| Disease | Melanoma, Harding-Passey | 3.69e-04 | 7 | 125 | 2 | C0018598 | |
| Disease | Meckel syndrome (implicated_via_orthology) | 4.90e-04 | 8 | 125 | 2 | DOID:0050778 (implicated_via_orthology) | |
| Disease | Developmental delay (disorder) | 5.19e-04 | 37 | 125 | 3 | C0424605 | |
| Disease | Nephronophthisis | 6.29e-04 | 9 | 125 | 2 | cv:C0687120 | |
| Disease | opportunistic bacterial infectious disease (implicated_via_orthology) | 6.29e-04 | 9 | 125 | 2 | DOID:0050340 (implicated_via_orthology) | |
| Disease | dyslexia | 6.47e-04 | 162 | 125 | 5 | EFO_0005424 | |
| Disease | Intellectual Disability | 6.55e-04 | 447 | 125 | 8 | C3714756 | |
| Disease | Meckel-Gruber syndrome | 7.84e-04 | 10 | 125 | 2 | cv:C0265215 | |
| Disease | alopecia areata (is_marker_for) | 7.84e-04 | 10 | 125 | 2 | DOID:986 (is_marker_for) | |
| Disease | Childhood Medulloblastoma | 8.09e-04 | 43 | 125 | 3 | C0278510 | |
| Disease | Melanotic medulloblastoma | 8.09e-04 | 43 | 125 | 3 | C1275668 | |
| Disease | Medullomyoblastoma | 8.09e-04 | 43 | 125 | 3 | C0205833 | |
| Disease | Desmoplastic Medulloblastoma | 8.09e-04 | 43 | 125 | 3 | C0751291 | |
| Disease | Adult Medulloblastoma | 8.09e-04 | 43 | 125 | 3 | C0278876 | |
| Disease | Peptic ulcer and gastro-oesophageal reflux disease (GORD) drug use measurement | 9.55e-04 | 11 | 125 | 2 | EFO_0009923 | |
| Disease | kidney cancer (implicated_via_orthology) | 9.55e-04 | 11 | 125 | 2 | DOID:263 (implicated_via_orthology) | |
| Disease | cancer (implicated_via_orthology) | 1.01e-03 | 268 | 125 | 6 | DOID:162 (implicated_via_orthology) | |
| Disease | Medulloblastoma | 1.26e-03 | 50 | 125 | 3 | C0025149 | |
| Disease | multiple myeloma | 1.34e-03 | 112 | 125 | 4 | EFO_0001378 | |
| Disease | Coffin-Siris syndrome | 1.35e-03 | 13 | 125 | 2 | C0265338 | |
| Disease | Bardet-Biedl syndrome (is_implicated_in) | 1.57e-03 | 14 | 125 | 2 | DOID:1935 (is_implicated_in) | |
| Disease | Kartagener syndrome (implicated_via_orthology) | 1.57e-03 | 14 | 125 | 2 | DOID:0050144 (implicated_via_orthology) | |
| Disease | Meckel-Gruber syndrome | 1.80e-03 | 15 | 125 | 2 | C0265215 | |
| Disease | schizophrenia (biomarker_via_orthology) | 1.80e-03 | 15 | 125 | 2 | DOID:5419 (biomarker_via_orthology) | |
| Disease | anemia (implicated_via_orthology) | 1.80e-03 | 15 | 125 | 2 | DOID:2355 (implicated_via_orthology) | |
| Disease | T-Cell Lymphoma | 2.05e-03 | 16 | 125 | 2 | C0079772 | |
| Disease | Disorder of eye | 2.13e-03 | 212 | 125 | 5 | C0015397 | |
| Disease | Child Behaviour Checklist assessment | 2.61e-03 | 18 | 125 | 2 | EFO_0005661 | |
| Disease | Meckel syndrome type 1 | 2.61e-03 | 18 | 125 | 2 | C3714506 | |
| Disease | photoreceptor cell layer thickness measurement | 3.68e-03 | 148 | 125 | 4 | EFO_0803370 | |
| Disease | Bronchiectasis | 3.89e-03 | 22 | 125 | 2 | C0006267 | |
| Disease | susceptibility to mumps measurement | 4.01e-03 | 75 | 125 | 3 | EFO_0008404 | |
| Disease | intellectual disability (implicated_via_orthology) | 4.01e-03 | 75 | 125 | 3 | DOID:1059 (implicated_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| ENGQREEEEEEKEPE | 931 | Q9UKV3 | |
| EEENPAEETGEEKQD | 6 | O43768 | |
| DEEETIEEEEANEGV | 951 | Q96L91 | |
| GETPTIEEGEEDEDE | 116 | P04920 | |
| EEEEEGESEAEPVEP | 141 | P48751 | |
| AEDSEGEEEEEEEEP | 31 | A6NC98 | |
| SEDEDEDFEERPEGQ | 1376 | Q8TDI0 | |
| GDEVEEEAEEPYEEA | 251 | P05067 | |
| DIGPATEEEEEEEEG | 86 | P0C2W7 | |
| GELESEPEEEEEEQA | 41 | Q2M329 | |
| EDEEEEESFPQPVDD | 241 | P51693 | |
| ENEEEEAQEPEETGP | 21 | Q5TZF3 | |
| GAVELEEEEENEEEA | 31 | Q96DT5 | |
| PDSDAEVDGVDEEEE | 156 | Q92688 | |
| LDEVDEDQEESIGEP | 391 | A6NHC0 | |
| EDDPEGDTEVDVIAE | 2026 | Q8TDJ6 | |
| SEEEEEEERVPEVES | 2696 | Q96M86 | |
| EDQVVEEGEEAAGEE | 581 | Q9GZS0 | |
| AEEEEDEEEVEEDGP | 256 | Q9Y3T6 | |
| EEEEEEEPQQRGQGE | 391 | P46060 | |
| AVETEEVEPDEEEFQ | 966 | Q5T8P6 | |
| DEEGDGEQEVEEEEV | 201 | Q2T9L4 | |
| VEGIIEEEEEDEEGS | 251 | Q9Y570 | |
| EEEEEGQEGVEEEDE | 1641 | O60840 | |
| DIGPATEEEEEEEGN | 86 | Q5JQC4 | |
| SEEEEEEVPEQEGEP | 326 | O95819 | |
| SFGPGNEEEEEEEEE | 986 | Q7RTP6 | |
| EDEEEEDNKTEETGP | 4786 | Q9NU22 | |
| EDTDNEEGEEENPLE | 4896 | Q9NU22 | |
| IDRGEDVPSEEEEEE | 176 | Q9ULX3 | |
| DVPSEEEEEEENGFE | 181 | Q9ULX3 | |
| QGSEAEEEEPEEEDD | 226 | Q9HBG6 | |
| PEVQEEEEEPQGDED | 166 | Q13477 | |
| AETEEAEEPEEDGEE | 946 | P46821 | |
| EDETEITEDLEPEVE | 1061 | Q68CZ1 | |
| PEESEAGNEEEEKEE | 291 | Q4G1C9 | |
| EESQEEDGDIEVEEA | 261 | Q9ULI0 | |
| EDGDIEVEEAEGEEN | 266 | Q9ULI0 | |
| PEEEEEEEEAAGVVV | 551 | P20700 | |
| TEREEEDEEIQEEGG | 111 | P0C7V8 | |
| EDEEIQEEGGEEEEE | 116 | P0C7V8 | |
| EDDEDETTVELEGQD | 61 | Q96A33 | |
| DEEEIEEELQGDDGV | 546 | Q9H501 | |
| PSEDIEGEDQEDKEE | 276 | Q6H9L7 | |
| DEQVEEEAVGEEEES | 781 | Q08499 | |
| SDSEEEEEGEEQEEI | 326 | A6NMT0 | |
| EHLDPDEEEEEGEVS | 2626 | Q6KC79 | |
| PLEEEEEEEDEDTRG | 1031 | Q14678 | |
| DEEEEVSDEVDGAEV | 386 | Q9H3R0 | |
| EEEEEEDGPAVLVEQ | 326 | P36915 | |
| GEEEEEAEESNVEDL | 1961 | Q07864 | |
| EQDSGILDVEDEEDD | 266 | Q9Y2D4 | |
| ILDVEDEEDDEEVPG | 271 | Q9Y2D4 | |
| DEEDDEEVPGAQDLV | 276 | Q9Y2D4 | |
| EEDEEEEEEEAVAVP | 706 | Q08379 | |
| HIIPENESDDEEEEE | 796 | Q3BBV0 | |
| TEEGDQEQDPEPEEE | 76 | Q8WY54 | |
| EPEEEAAVEGEEEEE | 86 | Q8WY54 | |
| PQGEAQEEEEEEEEE | 996 | Q96JP2 | |
| VSEEEEEEAEEGENE | 786 | Q92794 | |
| SEEEQQELEEPEPEE | 1286 | Q92794 | |
| DEDAQVVEDEEGEEE | 176 | O43423 | |
| ELGEEEEVEEEGDVD | 441 | P07199 | |
| VLDGVEDAEGEEEEE | 26 | Q14318 | |
| EEENESEPEEPSGVE | 161 | O60341 | |
| AGTNQEEEEGEEEEP | 216 | Q9P2K1 | |
| IEVEEGDEEEPAQDH | 436 | Q9Y3X0 | |
| FVTEPQEESEEEVEE | 141 | Q13283 | |
| EENTEEPPQGEEEES | 371 | Q12905 | |
| GPEEEEEEDFDDLTQ | 1456 | Q3T8J9 | |
| ESEEAEEEVGEGTPQ | 371 | Q9UQ88 | |
| SDLEEPAEGDEEEEE | 1031 | O60336 | |
| EEDNVEESEEEGPWE | 451 | Q9UBN7 | |
| EEEEDGVTEGLPEEQ | 146 | Q9BUN5 | |
| DEIPVLSEEGEEEEE | 11 | Q8IVF4 | |
| PVSEEGEEDEEQEAE | 501 | Q9NVU0 | |
| EEEQESVDTGEEEEG | 396 | Q9H9B1 | |
| EEEEEEEEAAAAVGP | 31 | P80192 | |
| EEEGEEDEERDEVGP | 11 | Q969X0 | |
| ENITEVGAPTEEEEE | 106 | O15259 | |
| PGEDTEEEEDEDVDS | 436 | O75807 | |
| EVNEPEEEEGSDNDD | 1051 | Q9HAU5 | |
| EEEEEETEEVAEAAG | 1241 | Q8N2Y8 | |
| QFVREPEDEEEEEEE | 26 | Q9NQC3 | |
| EEEEKADEGPEEVEQ | 571 | Q9H0K4 | |
| EIEVPLDDEDEEGEN | 381 | Q15542 | |
| EAEETDNEDEEEIEG | 731 | Q5TCS8 | |
| EEIEGDELEVHEEPE | 741 | Q5TCS8 | |
| AEEIEEEPAAGDDEE | 876 | O75691 | |
| EEPAAGDDEELEEEA | 881 | O75691 | |
| GDDEELEEEAVPQDE | 886 | O75691 | |
| GGQEEEEEEEEEAPV | 41 | O15211 | |
| EEQPEEEAAEEEEEA | 11 | P13805 | |
| GPVDSEDDEEEDEEI | 226 | Q8TEU7 | |
| LEHEEENEEEDEVPD | 1221 | P51531 | |
| NEEDVLGDETEEEET | 51 | P82979 | |
| HIIPENESDDEEEEE | 796 | Q5TAG4 | |
| IPENESDDEEEEEKG | 256 | Q8N660 | |
| IPENESDDEEEEEKG | 256 | A0A087WUL8 | |
| EPEEEEDTEDAGLDD | 491 | O60841 | |
| NDVDEDIIDVDEEPV | 181 | Q96QT6 | |
| GSEEEEEEEEEEQPQ | 661 | P51532 | |
| EEEVDIETEAVAPEE | 1231 | Q9UPS6 | |
| EAEEEEEGSVPETEL | 911 | Q01974 | |
| EEEEEEGSPQEEEEE | 661 | Q14160 | |
| EGSPQEEEEEEEEEN | 666 | Q14160 | |
| EEEEEGLEEDEPRFT | 571 | P23327 | |
| PQEDEEEDDEETIEV | 291 | Q6ZRS2 | |
| EEEEEETPEQPTAGD | 106 | Q9Y5Q9 | |
| GEEEEEEEEATNTHP | 171 | P10645 | |
| EEEEEEAEAGEEAVP | 231 | P10645 | |
| PAGREEEEEEEEEGT | 146 | Q96B54 | |
| EEEEEEVEDEEGGPR | 276 | Q9NUL5 | |
| LEEEENLPEEDSEEE | 971 | Q9UNS1 | |
| GQDLEFEEEEEEEEG | 41 | Q8N8E2 | |
| AEEEEETAEGEEPGE | 221 | P55822 | |
| GEVDTNHNEEDDEEP | 386 | Q05086 | |
| PGNLNESEEEEEEDD | 451 | O00541 | |
| SPSRGEDQEEEEEEE | 31 | M0QZC1 | |
| EDQEEEEEEEGDGSP | 36 | M0QZC1 | |
| EAPEAEEEAQEAEGE | 2056 | Q8IWN7 | |
| EEEAQEAEGEVQEAE | 2061 | Q8IWN7 | |
| PVGIEEDNDIEENED | 166 | Q9NP79 | |
| EVVEEEENGAEEEEE | 36 | P20962 | |
| EPEEEEEEAAAAEEG | 226 | O15370 | |
| EEEEEEEEEQQPATT | 1031 | Q9H7N4 | |
| DTEEEQVVPSEEDEA | 6 | Q5VZP5 | |
| SPEEEEEEEEEGSGE | 1351 | Q9BXM0 | |
| EEEILGSDDEEQEDP | 46 | P78362 | |
| VGAPEEEEEEEEDAG | 51 | P54274 | |
| QGEEEEEEEDGHSEQ | 311 | Q9UFB7 | |
| EEEEEEEEEEGPSEQ | 326 | Q9UFB7 | |
| DEEEDEETEVLLGDP | 766 | Q2VWA4 | |
| EVEEEEVEEAENEGE | 1071 | P37275 | |
| HQERPEEEGEDEAEA | 101 | F5GYI3 | |
| DSDEDDGPQRVEEVD | 111 | O95049 | |
| PDQEEEEEEEEKGEE | 26 | A6NFI3 | |
| DEEVEGWAEAVEPEE | 131 | Q13445 | |
| EDDDEDDDVPEGVER | 346 | Q9BTW9 | |
| QVEAEDVEESEGPSE | 251 | Q8WUA4 | |
| VEQDAEEEEAEEGPP | 231 | Q969S3 | |
| GEEGNEEEEEEEAAP | 21 | A0PJX2 | |
| DEPNVTSEEEEEEEE | 386 | Q6GMV2 | |
| EEEGPEEEDDDDIVD | 296 | Q9H4Z2 | |
| GEEEEEEEDTAAGEP | 381 | Q9NRD5 | |
| DEGEVEEEQQEEGEE | 236 | Q69YN4 | |
| GDTEEEEEEEVVPFS | 156 | O15231 | |
| EEEEEEEEEEGAGVP | 191 | C9JLR9 | |
| GPEAEEVQEEEELEE | 1486 | P41229 | |
| EVQEEEELEEETGGE | 1491 | P41229 | |
| LPSIVEDEEEEEEGE | 706 | Q96L42 | |
| NDVGEGEEEVEEEEE | 416 | Q96M32 | |
| QEESEEEEVDETGVE | 2026 | E9PAV3 | |
| QEEGETEAEAEGEEA | 566 | P07197 |